KR20110077851A - Triphenylene-based compounds and organic electroluminescent device comprising same - Google Patents

Triphenylene-based compounds and organic electroluminescent device comprising same Download PDF

Info

Publication number
KR20110077851A
KR20110077851A KR1020090134520A KR20090134520A KR20110077851A KR 20110077851 A KR20110077851 A KR 20110077851A KR 1020090134520 A KR1020090134520 A KR 1020090134520A KR 20090134520 A KR20090134520 A KR 20090134520A KR 20110077851 A KR20110077851 A KR 20110077851A
Authority
KR
South Korea
Prior art keywords
substituted
unsubstituted
aryl
compound
alkyl
Prior art date
Application number
KR1020090134520A
Other languages
Korean (ko)
Other versions
KR101196142B1 (en
Inventor
김신한
김태형
김경수
Original Assignee
주식회사 두산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 두산 filed Critical 주식회사 두산
Priority to KR1020090134520A priority Critical patent/KR101196142B1/en
Priority to PCT/KR2010/009508 priority patent/WO2011081451A2/en
Publication of KR20110077851A publication Critical patent/KR20110077851A/en
Application granted granted Critical
Publication of KR101196142B1 publication Critical patent/KR101196142B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06Six-membered rings
    • C07D327/08[b,e]-condensed with two six-membered carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/10Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B33/00Electroluminescent light sources
    • H05B33/12Light sources with substantially two-dimensional radiating surfaces
    • H05B33/14Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1096Heterocyclic compounds characterised by ligands containing other heteroatoms
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2101/00Properties of the organic materials covered by group H10K85/00
    • H10K2101/10Triplet emission
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE: A triphenylene-based compound is provided to ensure excellent hole injection and/or transport ability, and electron transport ability and/or light-emitting capability, and to improve luminous efficiency, brightness, driving voltage, and life span. CONSTITUTION: A triphenylene-based compound is represented by chemical formula 1, wherein X is sulfur or oxygen atoms. An organic electroluminescence device includes a positive electrode, a negative electrode, and a monolayered or multilayered organic layer interposed between the positive and negative electrodes. At least one of the organic layer comprises the triphenylene-based compound.

Description

트리페닐렌계 화합물 및 이를 포함하는 유기 전계 발광 소자 {TRIPHENYLENE-BASED COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME}Triphenylene-based compound and organic electroluminescent device including the same {TRIPHENYLENE-BASED COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME}

본 발명은 전자 수송능, 정공 주입 및/또는 수송능, 및/또는 발광능이 우수한 신규의 트리페닐렌계 화합물 및 이를 하나 이상의 유기층에 포함함으로써 발광효율, 휘도, 열적 안정성, 구동 전압, 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention includes a novel triphenylene compound having excellent electron transporting ability, hole injection and / or transporting ability, and / or luminous ability, and including the same in at least one organic layer, such as luminous efficiency, luminance, thermal stability, driving voltage, and lifetime. This is an improved organic electroluminescent device.

일반적으로 유기 발광 현상이란 유기 물질에 전기에너지를 가했을 때 빛이 나타나는 현상을 말한다. 즉, 양극(anode)과 음극(cathode) 사이에 유기층을 위치시켰을 때 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기층에 주입되게 된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되고, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다.In general, organic light emitting phenomenon refers to a phenomenon in which light appears when electric energy is applied to an organic material. That is, when the organic layer is positioned between the anode and the cathode, a voltage is applied between the two electrodes, and holes are injected into the organic layer and electrons are injected into the cathode. When the injected holes and electrons meet, excitons are formed, and when the excitons fall back to the ground, they shine.

1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광 (electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구는 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시 되었 고, 고효율, 고수명의 유기 EL 소자를 만들기 위하여 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. The study of organic electroluminescent (EL) devices (hereinafter simply referred to as 'organic EL devices') led to the blue electroluminescence using anthracene single crystals in 1965, based on Bernanose's observation of organic thin film emission. By (Tang), the organic EL device of the laminated structure divided into the functional layer of the hole layer and the light emitting layer has been presented, and has been developed in the form of introducing each characteristic organic material layer in the device to make a high efficiency and long life organic EL device. And has led to the development of specialized materials used therein.

이러한 유기 EL 소자는 ITO(Indium tin oxide) 기판, 양극, 선택적으로 양극으로부터 정공을 받아들이는 정공 주입층, 선택적으로 정공을 전달하는 정공 수송층, 정공과 전자가 재결합하여 빛을 내는 발광층, 선택적으로 전자를 전달하는 전자 수송층, 선택적으로 음극으로부터 전자를 받아들이는 전자 주입층 및 음극으로 이루어져 있다.Such organic EL devices include an indium tin oxide (ITO) substrate, an anode, a hole injection layer selectively receiving holes from an anode, a hole transport layer selectively transferring holes, a light emitting layer in which holes and electrons recombine to emit light, and optionally electrons It consists of an electron transporting layer for transferring the electrons, optionally an electron injection layer for receiving electrons from the cathode and the cathode.

이렇게 유기 EL 소자를 다층으로 제작하는 이유는 정공과 전자의 이동속도가 상이하기 때문인데, 적절한 정공 주입층, 정공 수송층, 전자 수송층 및 전자 주입층을 만들어 주면 정공과 전자가 효과적으로 전달될 수 있으며, 소자 내 정공과 전자의 균형이 이루어져 발광 효율을 높일 수 있다. The reason why the organic EL device is manufactured in multiple layers is that the movement speeds of the holes and the electrons are different. If the appropriate hole injection layer, the hole transport layer, the electron transport layer, and the electron injection layer are made, the holes and the electrons can be effectively transferred. The balance between the holes and the electrons in the device can be achieved to increase the luminous efficiency.

전자 주입층에서 주입된 전자와 정공 주입층에서 전달된 정공은 발광층에서 재결합하여 엑시톤을 형성하게 되며 일중항 여기 상태에서 기저 상태로 떨어지며 발광하는 것을 형광이라고 하고, 삼중항 여기 상태에서 기저 상태로 떨어지는 발광을 인광이라고 한다. 이론적으로 캐리어가 발광층에서 재결합하여 엑시톤이 발생될 때 일중항과 삼중항 여기자의 비율이 1:3의 비율로 발생되게 되며, 인광을 이용할 경우 내부 양자 효율이 100%에 이를 수 있다.Electrons injected from the electron injection layer and holes transferred from the hole injection layer recombine in the emission layer to form excitons, and fall from the singlet excited state to the ground state and are called fluorescence, and fall from the triplet excited state to the ground state. Luminescence is called phosphorescence. Theoretically, when the exciton is generated when the carrier is recombined in the emission layer, the ratio of singlet and triplet excitons is generated at a ratio of 1: 3, and when phosphorescence is used, the internal quantum efficiency may be 100%.

일반적으로 인광 호스트 재료로는 CBP(4,4-dicarbazolybiphenyl)등의 카바졸계 화합물 등이 사용되며, 인광 도판트 재료로는 Ir, Pt 등의 중원자(heavy atoms) 가 포함된 금속 착체 화합물이 널리 사용되고 있다. Generally, a carbazole compound such as CBP (4,4-dicarbazolybiphenyl) is used as the phosphorescent host material, and a metal complex compound containing heavy atoms such as Ir and Pt is widely used as the phosphorescent dopant material. It is used.

그러나 현재 사용되는 인광 호스트 재료인 CBP의 경우 유리전이온도(Tg)가 110℃ 정도로 낮으며, 소자 내의 결정화가 쉽게 일어나 유기 EL 소자의 수명이 150시간 정도로 매우 짧은 문제점이 있다.However, CBP, which is currently used phosphorescent host material, has a low glass transition temperature (Tg) of about 110 ° C., and crystallization in the device is easy, resulting in a very short lifespan of about 150 hours.

따라서, 본 발명의 목적은 우수한 전자 수송능, 정공 주입 및/또는 수송능 및/또는 발광능(형광 또는 인광)을 가진 트리페닐렌계 화합물 및 이를 하나 이상의 유기층에 포함함으로써 발광효율, 휘도, 열적 안정성, 구동 전압, 수명 등의 특성이 향상된 유기 EL 소자를 제공하는 것이다.Accordingly, an object of the present invention is to provide a triphenylene-based compound having excellent electron transporting ability, hole injection and / or transporting ability, and / or light emitting ability (fluorescence or phosphorescence) and light emission efficiency, brightness, and thermal stability by including the same in at least one organic layer. To provide an organic EL device having improved characteristics such as driving voltage and lifetime.

상기 목적을 달성하기 위하여 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:In order to achieve the above object, the present invention provides a compound represented by the following Chemical Formula 1:

Figure 112009081810135-PAT00001
Figure 112009081810135-PAT00001

상기 식에서, X는 황 또는 산소 원자이고; Wherein X is a sulfur or oxygen atom;

R1 내지 R20은 각각 독립적으로 수소, 중수소, 할로겐, 치환 또는 비치환된 C1-C40 알킬, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, 치환 또는 비치환된 C1-C40 알콕시, 치환 또는 비치환의 C3-C40 사이클로알킬, 치환 또는 비치환의 핵원자수 3 내지 40의 헤테로사이클로알킬, 치환 또는 비치환된 C5-C40 아릴, 치환 또는 비치환된 C5-C60 아릴옥시, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬, 치환 또는 비치환된 C2-C40 알케닐, 치환 또는 비치환된 C1-C40 알킬아민, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬아민, 치환 또는 비치환된 C1-C40 알킬실릴, 치환 또는 비치환된 C5-C40 아릴실릴, 치환 또는 비치환된 C7-C40 케토아릴, 치환 또는 비치환된 C1-C40 할로알킬 또는 시아노이며, R1 내지 R20은 서로 인접하는 기와 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있으며;R 1 to R 20 are each independently hydrogen, deuterium, halogen, substituted or unsubstituted C1-C40 alkyl, substituted or unsubstituted nuclear atom having 3 to 60 heterocycles, substituted or unsubstituted nuclear atom having 5 to 40 heteroaryl, substituted or unsubstituted C1-C40 alkoxy, substituted or unsubstituted C3-C40 cycloalkyl, substituted or unsubstituted heterocycloalkyl having 3 to 40 nuclear atoms, substituted or unsubstituted C5-C40 aryl, Substituted or unsubstituted C5-C60 aryloxy, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl, substituted or unsubstituted C2-C40 alkenyl, substituted or unsubstituted C1-C40 alkylamine, ( Substituted or unsubstituted C5-C60 aryl) C1-C40 alkylamine, substituted or unsubstituted C1-C40 alkylsilyl, substituted or unsubstituted C5-C40 arylsilyl, substituted or unsubstituted C7-C40 ketoaryl, substituted Or unsubstituted C1-C40 haloalkyl or cyano, R 1 to R 20 are adjacent to each other; May be combined with to form a fused aliphatic ring, a fused aromatic ring, a fused heteroaliphatic ring or a fused heteroaromatic ring having 5 to 40 nuclear atoms;

L은 치환 또는 비치환된 C5-C60 아릴, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬, 치환 또는 비치환된 C5-C40 아릴아민, 치환 또는 비치환된 C5-C60 아릴옥시, 치환 또는 비치환된 C5-C40 아릴실릴, 또는 치환 또는 비치환된 C7-C40 케토아릴이며, L이 치환기를 가질 경우 인접하는 치환기는 서로 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있다. L is substituted or unsubstituted C5-C60 aryl, substituted or unsubstituted heteroatom having 3 to 60 heteroatoms, substituted or unsubstituted heteroatom having 5 to 40 heteroaryl, (substituted or unsubstituted C5- C60 aryl) C1-C40 alkyl, substituted or unsubstituted C5-C40 arylamine, substituted or unsubstituted C5-C60 aryloxy, substituted or unsubstituted C5-C40 arylsilyl, or substituted or unsubstituted C7-C40 Ketoaryl, when L has a substituent, adjacent substituents may be bonded to each other to form a fused aliphatic ring, a fused aromatic ring, a fused heteroaliphatic ring, or a fused heteroaromatic ring having 5 to 40 nuclear atoms.

또한, 본 발명은, 양극; 음극; 및 상기 양극과 음극 사이에 개재(介在)된 하나 이상의 유기층을 포함하는 유기 EL 소자로서, 상기 유기층 중 적어도 하나는 상술된 화합물을 포함하는 것을 특징으로 하는 유기 EL 소자를 제공한다.In addition, the present invention, the anode; cathode; And at least one organic layer interposed between the anode and the cathode, wherein at least one of the organic layers includes the compound described above.

본 발명에 따른 상기 화학식 1의 화합물은 유기 EL 소자용 재료로 사용되어 넓은 에너지 밴드 갭을 통하여 청색, 녹색의 형광 또는 인광 호스트 재료로 채택될 경우 종래에 사용되는 4,4-dicarbazolybiphenyl (CBP)에 비해 저 전력, 고 효율, 고 휘도 및 향상된 내구성과 수명을 확보할 수 있다. 또한, 분자 내의 전자 특성 치환기와 정공 특성 치환기를 모두 포함함으로써, 양극과 음극 사이에 1층 이상의 유기층을 포함하는 유기 EL 소자의 정공 주입층, 정공 수송층, 및/또는 전자 수송층 재료로도 응용될 수 있다. 따라서 본 발명의 화합물을 포함하는 유기 EL 소자는 발광성능 및 수명 면에서 크게 향상될 수 있어 풀 칼라 디스플레이 패널 등에 효과적으로 적용될 수 있다.The compound of Chemical Formula 1 according to the present invention is used as a material for organic EL devices, and when used as a blue, green fluorescent or phosphorescent host material through a wide energy band gap, to 4,4-dicarbazolybiphenyl (CBP) conventionally used. Low power, high efficiency, high brightness, and improved durability and lifespan can be achieved. In addition, by including both the electronic substituent and the hole substituent in the molecule, it can be applied to the hole injection layer, hole transport layer, and / or electron transport layer material of the organic EL device including one or more organic layers between the anode and the cathode. have. Therefore, the organic EL device including the compound of the present invention can be greatly improved in terms of light emitting performance and lifetime, and thus can be effectively applied to a full color display panel and the like.

본 발명은 화학식 1로 표시되는 화합물, 구체적으로 삼중항 에너지 레벨이 적절하지 않아 인광 호스트로서의 특성을 충분히 발휘하지 못하는 트리페닐렌 모이어티(moiety)에, 아릴기를 함유한 링커(L)를 통해 d-오비탈을 가지는 S-함유 축합(fused) 헤테로환 모이어티(moiety)를 연결함으로써 오비탈 mixing을 통한 삼중항 에너지 레벨(Triplet energy state)을 안정하게 형성하는 효과를 유도함과 동시에 작용기에 의한 들뜬 에너지 레벨의 조절을 통한 3.0 eV < △ < 4.1 eV의 바람직 한 에너지 밴드갭을 형성하여 일반적인 인광 도판트와의 삼중항-삼중항 에너지 전이(triplet-triplet energy transition)를 잘 일으킬 수 있도록 유도하여, 소자의 인광특성을 개선함과 동시에 전자(electron) 및/또는 정공(hole) 수송 능력, 발광효율, 구동전압, 수명 특성 등에서 개선된 트리페닐렌계 화합물(triphenylene-based compound)을 제공한다. The present invention provides a compound represented by the formula (1), specifically, a triphenylene moiety that does not adequately exhibit its properties as a phosphorescent host due to inadequate triplet energy level, through a linker (L) containing an aryl group. The coupling of S-containing fused heterocyclic moieties with orbitals leads to the effect of stably forming the triplet energy state through orbital mixing and at the same time the excited energy level by the functional group By forming a desirable energy bandgap of 3.0 eV <△ <4.1 eV through the control of, it is possible to induce a triplet-triplet energy transition with a typical phosphorescent dopant, Triphenylene-based compounding with improved phosphorescence properties and improved electron and / or hole transport capacity, luminous efficiency, driving voltage and lifetime It provides (triphenylene-based compound).

본 발명의 화학식 1의 화합물에서, X는 황 또는 산소 원자이다. R1 내지 R20은 각각 독립적으로 수소 또는 임의의 치환체이며, 이러한 치환체는 바람직한 에너지 밴드갭을 형성할 수 있다면 특별히 한정되지 않으며, 이의 비-제한적인 예로는 중수소, 할로겐, 치환 또는 비치환된 C1-C40 알킬 (바람직하게는, C1-C8 알킬), 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환 (바람직하게는, 핵원자수 3 내지 24의 헤테로환), 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴 (바람직하게는, 핵원자수 5 내지 24의 헤테로아릴), 치환 또는 비치환된 C1-C40 알콕시 (바람직하게는, C1-C18 알콕시), 치환 또는 비치환된 C3-C40 사이클로알킬 (바람직하게는, C3-C18 사이클로알킬), 치환 또는 비치환된 핵원자수 3 내지 40 의 헤테로사이클로알킬 (바람직하게는, 핵원자수 3 내지 18의 헤테로사이클로알킬), 치환 또는 비치환된 C5-C40 아릴 (바람직하게는, C5-C24 아릴), 치환 또는 비치환된 C5-C60 아릴옥시 (바람직하게는, C5-C24 아릴옥시), (치환 또는 비치환된 C5-C60 아릴) C1-C40 알킬 (바람직하게는, (C5-C24 아릴)C1-C8 알킬), 치환 또는 비치환된 C2-C40 알케닐 (바람직하게는, C2-C18 알케닐), 치환 또는 비치환된 C1-C40 알킬아민 (바람직하게는, C1-C18 알킬아민), (치환 또는 비치환된 C5-C60 아릴) C1-C40 알킬 아민 (바람직하게는, (C5-C24 아릴)C1-C18 알킬아민), 치환 또는 비치환된 C1-C40 알킬실릴 (바람직하게는, C1-C18 알킬실릴), 치환 또는 비치환된 C5-C40 아릴실릴 (바람직하게는, C5-C18 아릴실릴), 치환 또는 비치환된 C7-C40 케토아릴 (바람직하게는, C7-C20 케토아릴), 치환 또는 비치환된 C1-C40 할로알킬 (바람직하게는, C1-C8 할로알킬), 시아노 등을 들 수 있으며, R1 내지 R20은 서로 인접하는 기와 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있다.In the compound of formula 1 of the present invention, X is a sulfur or oxygen atom. R 1 to R 20 are each independently hydrogen or an optional substituent, and such substituents are not particularly limited as long as they can form a desirable energy bandgap, and non-limiting examples thereof are deuterium, halogen, substituted or unsubstituted C1. -C40 alkyl (preferably C1-C8 alkyl), substituted or unsubstituted heterocyclic ring having 3 to 60 nuclear atoms (preferably heterocyclic ring having 3 to 24 nuclear atoms), substituted or unsubstituted nucleus Heteroaryl having 5 to 40 atoms (preferably heteroaryl having 5 to 24 nuclear atoms), substituted or unsubstituted C1-C40 alkoxy (preferably C1-C18 alkoxy), substituted or unsubstituted C3 -C40 cycloalkyl (preferably C3-C18 cycloalkyl), substituted or unsubstituted heterocycloalkyl having 3 to 40 nuclear atoms (preferably heterocycloalkyl having 3 to 18 nuclear atoms), substituted or Unsubstituted C5-C40 aryl (bar Directly C5-C24 aryl), substituted or unsubstituted C5-C60 aryloxy (preferably C5-C24 aryloxy), (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl (preferably Is (C5-C24 aryl) C1-C8 alkyl), substituted or unsubstituted C2-C40 alkenyl (preferably C2-C18 alkenyl), substituted or unsubstituted C1-C40 alkylamine (preferably , C1-C18 alkylamine), (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl amine (preferably (C5-C24 aryl) C1-C18 alkylamine), substituted or unsubstituted C1-C40 Alkylsilyl (preferably C1-C18 alkylsilyl), substituted or unsubstituted C5-C40 arylsilyl (preferably C5-C18 arylsilyl), substituted or unsubstituted C7-C40 ketoaryl (preferably , C7-C20 ketoaryl), substituted or unsubstituted C1-C40 haloalkyl (preferably C1-C8 haloalkyl), cyano, and the like, and R 1 to R 20 may be bonded to a group adjacent to each other. Within 5 nuclear atoms 40 condensed (fused) may form an aliphatic ring, a condensed aromatic ring, a condensed heterocyclic aliphatic ring or a condensed heteroaromatic ring.

상기 링커 L은 치환 또는 비치환된 C5-C60 아릴, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, (치환 또는 비치환된 C5-C60 아릴) C1-C40알킬, 치환 또는 비치환된 C5-C40 아릴아민, 치환 또는 비치환된 C5-C60 아릴옥시, 치환 또는 비치환된 C5-C40 아릴실릴, 또는 치환 또는 비치환된 C7-C40 케토아릴이며, L이 치환기를 가질 경우 인접하는 치환기는 서로 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있다. The linker L is substituted or unsubstituted C5-C60 aryl, substituted or unsubstituted heteroatoms having 3 to 60 nuclear atoms, substituted or unsubstituted heteroaryl atoms having 5 to 40 heteroatoms, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl, substituted or unsubstituted C5-C40 arylamine, substituted or unsubstituted C5-C60 aryloxy, substituted or unsubstituted C5-C40 arylsilyl, or substituted or unsubstituted C7 -C40 ketoaryl, where L has a substituent, adjacent substituents may be bonded to each other to form a fused aliphatic ring, a fused aromatic ring, a fused heteroaliphatic ring or a fused heteroaromatic ring having 5 to 40 nuclear atoms; have.

상기 L, R1 내지 R20의 알킬, 헤테로환, 헤테로아릴, 알콕시, 사이클로알킬, 헤테로사이클로알킬, 아릴, 아릴옥시, 아릴알킬, 알케닐, 알킬아민, 아릴알킬아민, 알킬실릴, 아릴실릴, 케토아릴, 및 할로알킬의 치환기는 각각 독립적으로 중수소, 할로겐, C1-C40 알킬, 핵원자수 3 내지 60의 헤테로환, 핵원자수 5 내지 40의 헤테 로아릴, C1-C40 알콕시, C3-C40 사이클로알킬, 핵원자수 3 내지 40의 헤테로사이클로알킬, C5-C40 아릴, C5-C60 아릴옥시, (C5-C60 아릴)C1-C40 알킬, C2-C40 알케닐, C1-C40 알킬아민, (C5-C60 아릴)C1-C40 알킬아민, C1-C40 알킬실릴, C5-C40 아릴실릴, C7-C40 케토아릴, C1-C40 할로알킬 및 시아노로 구성된 군에서 선택된 하나 이상일 수 있다. 또한, 이들 치환기는 각각 독립적으로 C1-C40 알킬, C5-C40 아릴, 핵원자수 5 내지 40의 헤테로아릴, 등으로 추가로 치환될 수 있다.Wherein L, R 1 to the R 20 alkyl, heterocycle, heteroaryl, alkoxy, cycloalkyl, heterocycloalkyl, aryl, aryloxy, arylalkyl, alkenyl, alkyl amines, arylalkyl amines, alkyl silyl, aryl silyl, The substituents of ketoaryl and haloalkyl are each independently deuterium, halogen, C1-C40 alkyl, heterocyclic ring having 3 to 60 nuclear atoms, heteroaryl having 5 to 40 nuclear atoms, C1-C40 alkoxy, C3-C40 Cycloalkyl, heterocycloalkyl having 3 to 40 nuclear atoms, C5-C40 aryl, C5-C60 aryloxy, (C5-C60 aryl) C1-C40 alkyl, C2-C40 alkenyl, C1-C40 alkylamine, (C5 -C60 aryl) C1-C40 alkylamine, C1-C40 alkylsilyl, C5-C40 arylsilyl, C7-C40 ketoaryl, C1-C40 haloalkyl and cyano. In addition, these substituents may each be further substituted with C1-C40 alkyl, C5-C40 aryl, heteroaryl having 5 to 40 nuclear atoms, and the like.

본 발명의 화학식 1의 화합물은 대표적인 예로서 하기 화학식 1a 또는 1b로 표현될 수 있다:Compounds of formula (I) of the present invention may be represented by the following formula (I) or formula (Ib) as a representative example:

Figure 112009081810135-PAT00002
Figure 112009081810135-PAT00002

Figure 112009081810135-PAT00003
Figure 112009081810135-PAT00003

상기 식에서,Where

X, L, R1 내지 R20은 앞서 정의된 바와 같다.X, L, R 1 to R 20 are as defined above.

링커 L은 하기 화학식 2로 구성된 군으로부터 선택될 수 있다:The linker L may be selected from the group consisting of

Figure 112009081810135-PAT00004
Figure 112009081810135-PAT00004

상기 식에서, Where

R21 내지 R24는 앞서 정의된 R1 내지 R20의 정의와 같다.R 21 to R 24 are the same as defined above for R 1 to R 20 .

링커 L은 하기 화학식 3으로 구성된 군으로부터 선택될 수도 있다:The linker L may also be selected from the group consisting of

Figure 112009081810135-PAT00005
Figure 112009081810135-PAT00005

상기 식에서,Where

R21 및 R22는 앞서 정의된 바와 같고,R 21 and R 22 are as defined above,

복수 개의 Z 중 적어도 하나는 질소 원자이고 나머지는 탄소 원자이며, Z에 부착된 수소 원자는 비치환되거나 중수소, 할로겐, 치환 또는 비치환된 C1-C40 알킬, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, 치환 또는 비치환된 C1-C40 알콕시, 치환 또는 비치환된 C3-C40 사이클로알킬, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로사이 클로알킬, 치환 또는 비치환된 C5-C40 아릴, 치환 또는 비치환된 C5-C60 아릴옥시, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬, 치환 또는 비치환된 C2-C40 알케닐, 치환 또는 비치환된 C1-C40 알킬아민, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬아민, 치환 또는 비치환된 C1-C40 알킬실릴, 치환 또는 비치환된 C5-C40 아릴실릴, 치환 또는 비치환된 C7-C40 케토아릴, 치환 또는 비치환된 C1-C40 할로알킬 또는 시아노로 치환될 수 있으며, 이들 치환기, R21 및 R22는 서로 인접하는 기와 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있다.At least one of the plurality of Z is a nitrogen atom and the rest are carbon atoms, and the hydrogen atom attached to Z is unsubstituted or deuterium, halogen, substituted or unsubstituted C1-C40 alkyl, substituted or unsubstituted nuclear atom, 3 to 3 Heteroaryl of 60, substituted or unsubstituted heteroaryl 5 to 40 heteroaryl, substituted or unsubstituted C1-C40 alkoxy, substituted or unsubstituted C3-C40 cycloalkyl, substituted or unsubstituted nuclear 3 To 40 heterocyclochloroalkyl, substituted or unsubstituted C5-C40 aryl, substituted or unsubstituted C5-C60 aryloxy, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl, substituted or unsubstituted C2-C40 alkenyl, substituted or unsubstituted C1-C40 alkylamine, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkylamine, substituted or unsubstituted C1-C40 alkylsilyl, substituted or unsubstituted C5-C40 arylsilyl, substituted or unsubstituted C7-C40 ketoaryl, substituted or non Hwandoen C1-C40 haloalkyl, or cyano, and the furnace may be substituted, these substituents, R 21 and R 22 are nuclear atoms combine groups which are adjacent to each other 5-40 condensed (fused) aliphatic ring, a condensed aromatic ring, a condensed heterocyclic aliphatic It may form a ring or a condensed heteroaromatic ring.

상기 링커 L은 트리페닐렌 및 S-함유 축합환과 메타 결합으로 연결된 형태가 바람직하다.The linker L is preferably a form in which the triphenylene and the S-containing condensed ring are linked by a meta bond.

하기 화학식들은 본 발명의 화학식 1의 화합물의 대표적인 예들이나, 본 발명의 화학식 1의 화합물이 하기 예시된 것들에 한정되는 것은 아니다.The following formulas are representative examples of the compounds of formula 1 of the present invention, but the compounds of formula 1 of the present invention are not limited to those illustrated below.

Figure 112009081810135-PAT00006
Figure 112009081810135-PAT00006

Figure 112009081810135-PAT00007
Figure 112009081810135-PAT00007

Figure 112009081810135-PAT00008
Figure 112009081810135-PAT00008

Figure 112009081810135-PAT00009
Figure 112009081810135-PAT00009

Figure 112009081810135-PAT00010
Figure 112009081810135-PAT00010

Figure 112009081810135-PAT00011
Figure 112009081810135-PAT00011

Figure 112009081810135-PAT00012
Figure 112009081810135-PAT00012

Figure 112009081810135-PAT00013
Figure 112009081810135-PAT00013

Figure 112009081810135-PAT00014
Figure 112009081810135-PAT00014

Figure 112009081810135-PAT00015
Figure 112009081810135-PAT00015

Figure 112009081810135-PAT00016
Figure 112009081810135-PAT00016

Figure 112009081810135-PAT00017
Figure 112009081810135-PAT00017

Figure 112009081810135-PAT00018
Figure 112009081810135-PAT00018

Figure 112009081810135-PAT00019
Figure 112009081810135-PAT00020
Figure 112009081810135-PAT00019
Figure 112009081810135-PAT00020

Figure 112009081810135-PAT00021
Figure 112009081810135-PAT00021

Figure 112009081810135-PAT00022
Figure 112009081810135-PAT00022

Figure 112009081810135-PAT00023
Figure 112009081810135-PAT00023

본 발명에서 사용된 "비치환된 알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소이며, 이의 예로는 메틸, 에틸, 프로필, 이소부틸. sec-부틸, 펜틸, iso-아밀, 헥실 등을 포함한다. As used herein, "unsubstituted alkyl" is a straight or branched chain saturated hydrocarbon of 1 to 40 carbon atoms, examples being methyl, ethyl, propyl, isobutyl. sec-butyl, pentyl, iso-amyl, hexyl and the like.

"비치환된 사이클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소 그룹을 포함한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 놀보닐(norbornyl), 등이 포함되지만 이에 한정되는 것은 아니다. "Unsubstituted cycloalkyl" includes monocyclic or polycyclic non-aromatic hydrocarbon groups having 3 to 40 carbon atoms. Examples of such cycloalkyls include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, and the like.

"비치환된 알콕시"는 1 내지 40개의 탄소 원자가 산소와 부착된 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함하는 것으로 해석한다. 알콕시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등이 포함될 수 있으며 이에 한정되지는 않는다. "Unsubstituted alkoxy" means alkyl with 1 to 40 carbon atoms attached to oxygen and is interpreted to include a linear, branched or cyclic structure. Examples of alkoxy may include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.

"비치환된 헤테로환(heterocycle)"은 핵원자수 3 내지 60의 방향족 및/또는 비-방향족 고리를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로원자로 치환된다. 헤테로환의 비-제한적인 예로는 3-1H-벤즈이미다졸-2-온, 2-테트라히드로퓨라닐, 2-테트라히드로티오페닐, 2-모르폴리닐, 3-모르폴리닐, 1-피롤리디닐, 1-피페라지닐, 2-피페라지닐, 4-티아졸리디닐, 벤족사닐(benzoxanyl), 벤조피롤리디닐(benzopyrrolidinyl), 벤조피페리디닐(benzopiperidinyl), 벤조티아닐(benzothianyl) 등이 포함된다. 나아가, 본원에서 사용된 헤테로환은 하나 이상의 방향족 또는 비-방향족 고리와 축합된 것도 포함하는 것으로 해석한다. 본 발명에서 헤테로환은 헤테로사이클로알킬 및 헤테로아릴과 중첩적인 의미로 사용될 수도 있다."Unsubstituted heterocycle" means an aromatic and / or non-aromatic ring having 3 to 60 nuclear atoms, wherein one or more carbons in the ring, preferably 1 to 3 carbons, are N, O or S And substituted with a heteroatom such as Non-limiting examples of heterocycles include 3-1H-benzimidazol-2-one, 2-tetrahydrofuranyl, 2-tetrahydrothiophenyl, 2-morpholinyl, 3-morpholinyl, 1-pyrroli Dinyl, 1-piperazinyl, 2-piperazinyl, 4-thiazolidinyl, benzoxanyl, benzopyrrolidinyl, benzopiperidinyl, benzothianyl, etc. This includes. Furthermore, the heterocycles used herein are to be understood to include those condensed with one or more aromatic or non-aromatic rings. In the present invention, the heterocycle may be used in a superposition with heterocycloalkyl and heteroaryl.

"비치환된 아릴"은 단독 고리 혹은 2 이상의 고리가 조합된, 탄소수 5 내지 60의 방향족 부위를 의미하며, 본원에서 "아릴옥시", "아릴알킬", "아릴실릴" 등에서 언급되고 있다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된(fused) 형태로 부착될 수 있다. 아릴의 예로는 페닐, 히드록시페닐, 알콕시페닐, 나프틸, 페난트릴, 안트릴 등이 포함되며 이에 한정되는 것은 아니다. "Unsubstituted aryl" means an aromatic moiety having 5 to 60 carbon atoms, singly or in combination of two or more rings, and is referred to herein as "aryloxy", "arylalkyl", "arylsilyl", and the like. Two or more rings may be attached in a simple or fused form with one another. Examples of aryl include, but are not limited to, phenyl, hydroxyphenyl, alkoxyphenyl, naphthyl, phenanthryl, anthryl, and the like.

"비치환된 헤테로아릴"은 핵원자수 5 내지 40의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 부위를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로원자로 치환된다. 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된(fused) 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함하는 것으로 해석한다. 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리를 포함하고, 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등도 포함하는 것으로 해석한다. "Unsubstituted heteroaryl" means a monoheterocyclic or polyheterocyclic aromatic moiety having 5 to 40 nuclear atoms, wherein at least one carbon in the ring, preferably 1 to 3 carbons, is N, O or S And substituted with a heteroatom such as It is understood that two or more rings may be attached in a simple or fused form to each other and further include a condensed form with an aryl group. Examples of heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl; Polycyclics such as phenoxathienyl, indolinzinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl It is understood to include a ring and to include 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl, and the like.

“비치환된 헤테로사이클로알킬”은 핵원자수 3 내지 40의 비-방향족 부위를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로 원자로 치환된다. 이의 비-제한적인 예로는 모르폴린, 피페라진 등이 있다.“Unsubstituted heterocycloalkyl” means a non-aromatic moiety having 3 to 40 nuclear atoms, in which one or more carbons in the ring, preferably 1 to 3 carbons, are replaced with a hetero atom such as N, O or S . Non-limiting examples thereof include morpholine, piperazine and the like.

"비치환된 알케닐(alkenyl)"은 탄소 수 2 내지 40의 알킬의 중앙 또는 말단에 하나 이상의 탄소-탄소 이중결합을 포함하는 라디칼을 의미한다. 알케닐의 예로는 에틸렌, 프로필렌, 부틸렌, 헥실렌 등을 포함하며, 이에 한정되는 것은 아니다. "Unsubstituted alkenyl" means a radical comprising at least one carbon-carbon double bond at the center or terminus of an alkyl having from 2 to 40 carbon atoms. Examples of alkenyl include, but are not limited to, ethylene, propylene, butylene, hexylene, and the like.

"비치환된 아릴옥시"는 탄소수 5 내지 60의 페닐옥시, 나프틸옥시, 디페닐옥시 등을 포함하고, "비치환된 아릴알킬(arylalkyl)"은 아랄킬(aralkyl)로도 불리며 벤질, 페닐에틸 등을 포함한다. "Unsubstituted aryloxy" includes phenyloxy, naphthyloxy, diphenyloxy and the like having 5 to 60 carbon atoms, and "unsubstituted arylalkyl" is also called aralkyl and benzyl, phenylethyl And the like.

"알킬실릴"은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 40의 아릴로 치환된 실릴이며, "케토아릴(ketoaryl)"은 카보닐기가 부착된 아릴을 의미하며, "할로알킬 (haloalkyl)"은 불소, 염소, 브롬 등의 할로겐 원자로 치환된 알킬을 의미한다."Alkylsilyl" is silyl substituted with alkyl having 1 to 40 carbon atoms, "arylsilyl" is silyl substituted with aryl having 5 to 40 carbon atoms, and "ketoaryl" means aryl having a carbonyl group attached thereto. "Haloalkyl" refers to alkyl substituted with halogen atoms such as fluorine, chlorine, bromine and the like.

본 발명의 화학식 1의 화합물은 일반적인 합성방법에 따라 합성될 수 있다(Chem . Rev ., 60:313 (1960); J. Chem . SOC. 4482 (1955); Chem. Rev. 95: 2457 (1995) 등 참조). 본 발명의 화합물에 대한 상세한 합성 과정은 후술하는 합성예에서 구체적으로 기술하도록 한다. The compounds of general formula (I) of the present invention can be synthesized according to the general synthetic method (Chem Rev, 60: 313 ( 1960); J. Chem SOC 4482 (1955); Chem Rev. 95:..... 2457 (1995 ) And so on). Detailed synthesis procedures for the compounds of the present invention will be described in detail in the synthesis examples described below.

본 발명은 또한 양극(anode); 음극(cathode); 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기층을 포함하는 유기 EL 소자로서, 상기 1층 이상의 유기층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 EL 소자를 제공한다. The invention also includes an anode; Cathode; And at least one organic layer interposed between the anode and the cathode, wherein at least one of the at least one organic layer comprises a compound represented by Formula 1 above. To provide.

상기 화학식 1의 화합물은 단독 또는 복수로 포함될 수 있다.The compound of Formula 1 may be included alone or in plurality.

본 발명의 화학식 1의 화합물을 포함하는 유기층은 정공주입층, 정공수송층, 전자수송층 및 발광층 중 어느 하나 이상일 수 있다. 본 발명에서 발광층은 인광 도판트 재료 또는 형광 도판트 재료를 포함할 수 있다. 바람직하게는, 본 발명의 화학식 1의 화합물은 청색, 녹색, 및/또는 적색의 인광 호스트, 형광 호스트, 정공수송 물질, 정공주입 물질 및/또는 전자수송물질로서 유기 EL 소자에 포함될 수 있다. 보다 바람직하게는 본 발명의 화학식 1의 화합물은 인광 호스트 또는 형광 호스트, 특히 바람직하게는 인광 호스트로서 유기 EL 소자에 포함될 수 있다. The organic layer including the compound of Formula 1 of the present invention may be any one or more of a hole injection layer, a hole transport layer, an electron transport layer and a light emitting layer. In the present invention, the light emitting layer may include a phosphorescent dopant material or a fluorescent dopant material. Preferably, the compound of formula 1 of the present invention may be included in the organic EL device as a blue, green, and / or red phosphorescent host, a fluorescent host, a hole transport material, a hole injection material and / or an electron transport material. More preferably, the compound of formula 1 of the present invention may be included in the organic EL device as a phosphorescent host or a fluorescent host, particularly preferably as a phosphorescent host.

본 발명의 화합물은 150℃ 이상의 높은 유리 전이 온도를 가지고 있어, 이러한 화합물을 유기 EL 소자의 유기층으로 사용할 경우 유기 EL 소자 내에서 결정화가 최소화되기 때문에 소자의 구동전압을 낮출 수 있고, 발광효율, 휘도, 열적 안정성, 및 수명 특성을 개선할 수 있다.Since the compound of the present invention has a high glass transition temperature of 150 ℃ or more, when the compound is used as an organic layer of the organic EL device, since the crystallization is minimized in the organic EL device, the driving voltage of the device can be lowered, luminous efficiency, luminance , Thermal stability, and lifetime characteristics can be improved.

본 발명에 따른 유기 EL 소자 구조의 비제한적인 예를 들면, 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극이 순차적으로 적층된 것일 수 있으며, 이때 상기 발광층, 정공주입층, 정공수송층 및 전자수송층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 상기 전자 수송층 위에 는 전자 주입층이 위치할 수도 있다.As a non-limiting example of the organic EL device structure according to the present invention, a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer and a cathode may be sequentially stacked, wherein the light emitting layer, hole injection layer, At least one of the hole transport layer and the electron transport layer may include a compound represented by Chemical Formula 1. The electron injection layer may be positioned on the electron transport layer.

또한, 본 발명에 따른 유기 EL 소자는 전술한 바와 같이 양극, 1층 이상의 유기층 및 음극이 순차적으로 적층된 구조뿐만 아니라, 전극과 유기층 계면에 절연층 또는 접착층이 삽입될 수도 있다.In addition, as described above, the organic EL device according to the present invention may not only have a structure in which an anode, at least one organic layer, and a cathode are sequentially stacked, but an insulating layer or an adhesive layer may be inserted at the interface between the electrode and the organic layer.

본 발명의 유기 EL 소자에 있어서, 상기 화학식 1의 화합물을 포함하는 상기 유기층은 진공 증착이나 용액 도포에 의하여 형성될 수 있다. 상기 용액 도포의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에만 한정되지 않는다. In the organic EL device of the present invention, the organic layer including the compound of Formula 1 may be formed by vacuum deposition or solution coating. Examples of the solution application include spin coating, dip coating, doctor blading, inkjet printing or thermal transfer method, but is not limited thereto.

본 발명의 유기 EL 소자는, 유기층 중 1층 이상을 본 발명의 화학식 1로 표현된 화합물을 포함하도록 형성하는 것을 제외하고는, 당 기술 분야에 알려져 있는 재료 및 방법을 이용하여 유기층 및 전극을 형성할 수 있다.The organic EL device of the present invention forms an organic layer and an electrode using materials and methods known in the art, except that at least one of the organic layers is formed to include the compound represented by the formula (1) of the present invention. can do.

예컨대, 기판으로는 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름이나 시트 등이 사용될 수 있다.For example, a silicon wafer, quartz, glass plate, metal plate, plastic film or sheet may be used as the substrate.

양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합물; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자; 또는 카본블랙 등이 있으나, 이들에만 한정되는 것은 아니다.The anode material may be a metal such as vanadium, chromium, copper, zinc, gold or an alloy thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO); Combinations of oxides with metals such as ZnO: Al or SnO 2 : Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole and polyaniline; Or carbon black, but is not limited thereto.

음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리 튬, 가돌리늄, 알루미늄, 은, 주석 또는 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다.Cathode materials include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin or lead or alloys thereof; Multilayer structure materials such as LiF / Al or LiO 2 / Al, and the like, but are not limited thereto.

정공 주입층, 정공 수송층, 전자 수송층 및 전자 주입층은 특별히 한정되는 것은 아니며, 당 업계에 알려진 통상의 물질이 사용될 수 있다.The hole injection layer, the hole transport layer, the electron transport layer and the electron injection layer are not particularly limited, and conventional materials known in the art may be used.

이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following Examples. However, the following examples are merely to illustrate the present invention and the present invention is not limited by the following examples.

<준비예 1> 4,4,5,5-Tetramethyl-2-(triphenylene-2-yl)-1,3,2-dioxaborolane의 합성Preparation Example 1 Synthesis of 4,4,5,5-Tetramethyl-2- (triphenylene-2-yl) -1,3,2-dioxaborolane

<< 단계 1> 2-Bromotriphenylene의 합성Step 1> Synthesis of 2-Bromotriphenylene

Figure 112009081810135-PAT00024
Figure 112009081810135-PAT00024

Triphenylene(50 g, 219.0 mmol)을 Chloroform 750 ㎖와 Trimethyl phosphate 51 ㎖(438.0 mmol)에 용해시킨 후 용액을 질소 분위기에서 60℃로 가열, 교반하였다. Triphenylene (50 g, 219.0 mmol) was dissolved in 750 ml of Chloroform and 51 ml (438.0 mmol) of Trimethyl phosphate, and the solution was heated and stirred at 60 ° C. in a nitrogen atmosphere.

반응 혼합물에 Bromine(35g, 219.0 mmol)을 9시간 동안 천천히 적가하고, 3시 간 더 질소 분위기에서 60℃로 가열, 교반한 후 상온으로 식힌 뒤, 포화 Sodium thiosulphate 수용액(350 ml)를 첨가하여 반응을 종결한 뒤, 분리깔데기를 이용하여 유기용액만을 받아 낸 뒤, Brine 50 ml로 3회 세정하였다. Bromine (35 g, 219.0 mmol) was slowly added dropwise to the reaction mixture for 9 hours, heated at 60 ° C. in a nitrogen atmosphere for 3 hours, stirred, and cooled to room temperature, followed by addition of a saturated aqueous sodium thiosulphate solution (350 ml). After terminating, only the organic solution was taken out using a separatory funnel, and then washed three times with 50 ml of Brine.

추출액을 과량의 Magnesium sulphate로 건조한 후 여과, 세척하고 여액을 감압 농축하였다. 농축물을 과량의 Dichloromethane에 녹여 Silica gel을 이용하여 여과하고 감압 농축한 다음 Acetone/Hexane (500 ml/2000 ml)으로 재결정한 후 여과, 건조하여 백색 고형의 표제 화합물(56g, 수율: 83%)을 수득하였다. The extract was dried with excess Magnesium sulphate, filtered and washed, and the filtrate was concentrated under reduced pressure. The concentrate was dissolved in excess dichloromethane, filtered using Silica gel, concentrated under reduced pressure, recrystallized from Acetone / Hexane (500 ml / 2000 ml), filtered and dried to give the title compound as a white solid (56 g, yield: 83%). Obtained.

GC-Mass (이론치: 306.00 g/mol, 측정치: 306 g/mol) GC-Mass (Theoretical value: 306.00 g / mol, Measured value: 306 g / mol)

<단계 2> 4,4,5,5-<Step 2> 4,4,5,5- TetramethylTetramethyl -2-(-2-( triphenylenetriphenylene -2--2- ylyl )-1,3,2-) -1,3,2- dioxaborolanedioxaborolane 의 합성Synthesis of

Figure 112009081810135-PAT00025
Figure 112009081810135-PAT00025

상기 <단계 1>에서 얻어진 화합물 (50 g, 164 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (83 g, 327 mmol), Pd(dffp)2Cl2 (4.08 g, 4.92 mmol), 및 potassium acetate (48 g, 490 mmol)을 플라스크에 넣고 질소 분위기 하에 1,4-dioxane 810 ㎖에 용해시킨 다음 12시간 동안 환류 교반하였다. Compound (50 g, 164 mmol) obtained in <Step 1>, 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1,3,2 -dioxaborolane) (83 g, 327 mmol), Pd (dffp) 2Cl2 (4.08 g, 4.92 mmol), and potassium acetate (48 g, 490 mmol) were added to the flask and dissolved in 810 ml of 1,4-dioxane under nitrogen atmosphere. It was then stirred at reflux for 12 hours.

반응이 종결된 후 얼음물 400 ml를 첨가하고 디클로로메탄 50 ml로 3회 추출 한 다음 얻어진 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물(crude product)을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 표제 화합물(40.5 g, 수율 68 %)을 수득하였다.After the reaction was completed, 400 ml of iced water was added, extracted three times with 50 ml of dichloromethane, and the obtained extract was dried with excess Magnesium sulphate, filtered, and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to afford the title compound (40.5 g, yield 68%) as a white solid.

GC-Mass (이론치: 354.18 g/mol, 측정치: 354 g/mol) GC-Mass (Theoretical value: 354.18 g / mol, Measured value: 354 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 1.4(S, 12H), 7.65(m, 4H), 8.0(m, 2H), 8.73(m, 3H), 8.78(m, 2H), 9.14(S, 1H) 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 1.4 (S, 12H), 7.65 (m, 4H), 8.0 (m, 2H), 8.73 (m, 3H), 8.78 (m, 2H) , 9.14 (S, 1 H)

<< 합성예Synthetic example 1> 화합물  1> Compound InvInv A-2의 합성 Synthesis of A-2

Figure 112009081810135-PAT00026
Figure 112009081810135-PAT00026

<단계 1> 화합물 1의 합성Step 1 Synthesis of Compound 1

Thianthren-1-ylboronic acid(10.2g, 39.3mmol), 1-bromo-3-Iodobenzene (16.7 g, 58.9 mmol) 및 Pd(PPh3)4 (0.45 g, 0.393 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 196 ㎖와 Ethanol 98 ㎖의 혼합용매에 용해시킨 후 Potassium Carbonate(8.1 g, 58.9 mmol)을 녹인 수용액 98 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Thianthren-1-ylboronic acid (10.2 g, 39.3 mmol), 1-bromo-3-Iodobenzene (16.7 g, 58.9 mmol) and Pd (PPh 3 ) 4 (0.45 g, 0.393 mmol) were added to the flask and toluene under nitrogen atmosphere. After dissolving in a mixed solvent of 196 mL and 98 mL of Ethanol, 98 mL of an aqueous solution of Potassium Carbonate (8.1 g, 58.9 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 표제 화합물(9.5 g, 수율 65 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give the title compound (9.5 g, yield 65%) as a white solid.

GC-Mass (이론치: 369.95 g/mol, 측정치: 369 g/mol)GC-Mass (Theoretical value: 369.95 g / mol, Measured value: 369 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv A-2의 합성 Synthesis of A-2

상기 준비예 1에서 최종 합성한 화합물(7.12 g, 20.09mmol), 상기 <단계 1>에서 합성한 화합물 1(7.4g, 20.09mmol), 및 Pd(PPh3)4 (0.23 g, 0.201 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 133 ㎖에 용해시킨 후 Potassium Carbonate(5.55 g, 40.2 mmol)을 녹인 수용액 67 ㎖를 첨가하고 12시간 동안 환류 교반하였다. Compound (7.12 g, 20.09 mmol) finally synthesized in Preparation Example 1, Compound 1 (7.4 g, 20.09 mmol) synthesized in <Step 1>, and Pd (PPh 3 ) 4 (0.23 g, 0.201 mmol) were prepared. The flask was dissolved in 133 ml of Toluene under a nitrogen atmosphere, and 67 ml of an aqueous solution of Potassium Carbonate (5.55 g, 40.2 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv A-2(6.2 g, 수율 60 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv A-2 (6.2 g, yield 60%) as a white solid.

GC-Mass (이론치: 518.69 g/mol, 측정치: 518 g/mol)GC-Mass (Theoretical value: 518.69 g / mol, Measured value: 518 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.80(m, 2H), 6.86(m, 1H), 6.96(m, 1H), 7.00(m, 3H), 7.33(m, 1H), 7.44(m, 2H), 7.70(S, 1H), 7.82(m, 1H), 7.88(m, 2H), 8.04(m, 1H), 8.12(m, 2H), 8.18(m, 1H), 8.93(m, 2H), 9.15(S, 1H) 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.80 (m, 2H), 6.86 (m, 1H), 6.96 (m, 1H), 7.00 (m, 3H), 7.33 (m, 1H) , 7.44 (m, 2H), 7.70 (S, 1H), 7.82 (m, 1H), 7.88 (m, 2H), 8.04 (m, 1H), 8.12 (m, 2H), 8.18 (m, 1H), 8.93 (m, 2 H), 9.15 (S, 1 H)

<< 합성예Synthetic example 2> 화합물  2> compound InvInv A-4의 합성 Synthesis of A-4

Figure 112009081810135-PAT00027
Figure 112009081810135-PAT00027

<단계 1> 화합물 2의 합성Step 1 Synthesis of Compound 2

Thianthren-1-ylboronic acid (10.2g, 39.3mmol), 1,3-Dibromo-5-fluorobenzene 15 g (58.9 mmol) 및 Pd(PPh3)4 (0.45 g, 0.393 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 196 ㎖와 Ethanol 98 ㎖의 혼합용매에 용해시킨 후 Sodium carbonate (6.3 g, 58.9 mmol)을 녹인 수용액 98 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Thianthren-1-ylboronic acid (10.2 g, 39.3 mmol), 15 g (58.9 mmol) of 1,3-Dibromo-5-fluorobenzene and Pd (PPh 3 ) 4 (0.45 g, 0.393 mmol) were placed in a flask and placed under a nitrogen atmosphere. After dissolving in a mixed solvent of 196 ml of toluene and 98 ml of ethanol, 98 ml of an aqueous solution of sodium carbonate (6.3 g, 58.9 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 2(9.1 g, 수율 60 %)을 수득하였다After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 2 (9.1 g, yield 60%) as a white solid.

GC-Mass (이론치: 387.94 g/mol, 측정치: 387 g/mol)GC-Mass (Theoretical value: 387.94 g / mol, Measured value: 387 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv A-4의 합성 Synthesis of A-4

상기 준비예 1에서 최종 합성한 화합물(7.5 g, 21.17mmol), 상기 <단계 1>에서 합성한 화합물 2(7.4g, 19.25mmol) 및 Pd(PPh3)4 (0.22 g, 0.193 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 128 ㎖에 용해시킨 후 Sodium carbonate (4.1 g, 38.5 mmol)을 녹인 수용액 64 ㎖를 첨가하여 12시간 동안 환류 교반하였다.The compound (7.5 g, 21.17 mmol) finally synthesized in Preparation Example 1, flask 2 (7.4 g, 19.25 mmol) and Pd (PPh 3 ) 4 (0.22 g, 0.193 mmol) synthesized in <Step 1> were flasked. After dissolving in 128 ml of Toluene under nitrogen atmosphere, 64 ml of an aqueous solution of sodium carbonate (4.1 g, 38.5 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응 종료 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv A-4(7.4 g, 수율 72 %)을 수득하였다.After completion of the reaction, the mixture was extracted three times with 50 ml of dichloromethane, and the extract was dried over Magnesium sulphate, filtered, and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv A-4 (7.4 g, 72% yield) as a white solid.

GC-Mass (이론치: 536.68 g/mol, 측정치: 536 g/mol)GC-Mass (Theoretical value: 536.68 g / mol, Measured value: 536 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.80~6.86(m, 3H), 6.96~7.02(m, 4H), 7.15(m, 2H), 7.47(S, 1H), 7.82~7.88(m, 4H), 8.04(m, 1H), 8.12~8.18(m, 3H), 8.93(m, 2H), 9.15(S, 1H) 1 H-NMR (THF-d 8 , 500MHz) d (ppm) 6.80 ~ 6.86 (m, 3H), 6.96 ~ 7.02 (m, 4H), 7.15 (m, 2H), 7.47 (S, 1H), 7.82 ~ 7.88 (m, 4H), 8.04 (m, 1H), 8.12-8.18 (m, 3H), 8.93 (m, 2H), 9.15 (S, 1H)

<< 합성예Synthetic example 3> 화합물  3> Compound InvInv A-12의 합성 Synthesis of A-12

Figure 112009081810135-PAT00028
Figure 112009081810135-PAT00028

<단계 1> 화합물 3의 합성<Step 1> Synthesis of Compound 3

Thianthren-1-ylboronic acid (30 g, 22.58 mmol), 1,3,5-Tribromobenzene (84.7 g, 22.58 mmol) 및 Pd(PPh3)4 (0.26 g, 0.226 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 151 ㎖에 용해시킨 후 Sodium carbonate (4.8 g, 45.2 mmol)을 녹인 수용액 75 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Thianthren-1-ylboronic acid (30 g, 22.58 mmol), 1,3,5-Tribromobenzene (84.7 g, 22.58 mmol) and Pd (PPh 3 ) 4 (0.26 g, 0.226 mmol) were added to the flask and toluene under nitrogen atmosphere. After dissolving in 151 mL, 75 mL of an aqueous solution of sodium carbonate (4.8 g, 45.2 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응 종료 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 3(10.2 g, 수율 83 %)을 수득하였다.After completion of the reaction, the mixture was extracted three times with 50 ml of dichloromethane, and the extract was dried over Magnesium sulphate, filtered, and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 3 (10.2 g, yield 83%) as a white solid.

GC-Mass (이론치: 447.86 g/mol, 측정치: 447 g/mol)GC-Mass (Theoretical value: 447.86 g / mol, Measured value: 447 g / mol)

<단계 2> 화합물 4의 합성Step 2 Synthesis of Compound 4

상기 <단계 1>에서 합성한 화합물 3(20.0g, 44.9mmol), 3-Pyridineboronic acid (5.52 g, 44.9 mmol) 및 Pd(PPh3)4 (0.52 g, 0.449 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 225 ㎖와 Ethanol 112 ㎖의 혼합용매에 용해시킨 후 Sodium carbonate (6.3 g, 58.9 mmol)을 녹인 수용액 112 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Compound 3 (20.0 g, 44.9 mmol), 3-Pyridineboronic acid (5.52 g, 44.9 mmol) and Pd (PPh 3 ) 4 (0.52 g, 0.449 mmol) synthesized in <Step 1> were placed in a flask under nitrogen atmosphere. After dissolving in a mixed solvent of 225 ml of toluene and 112 ml of ethanol, 112 ml of an aqueous solution of sodium carbonate (6.3 g, 58.9 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피 (n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 4(13 g, 수율 65 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 4 (13 g, yield 65%) as a white solid.

GC-Mass (이론치: 446.98 g/mol, 측정치: 447 g/mol)GC-Mass (Theoretical value: 446.98 g / mol, Measured value: 447 g / mol)

<단계 3> 화합물 <Step 3> Compound InvInv A-12의 합성 Synthesis of A-12

상기 준비예 1에서 최종 합성한 화합물(8.0 g, 22.58mmol), 상기 <단계 2>에서 합성한 화합물 4(10.1g, 22.58mmol) 및 Pd(PPh3)4 (0.26 g, 0.226 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 151 ㎖에 용해시킨 후 Sodium carbonate (4.8 g, 45.2 mmol)을 녹인 수용액 75 ㎖를 첨가하여 12시간 동안 환류 교반하였다. The compound (8.0 g, 22.58 mmol) finally synthesized in Preparation Example 1, Compound 4 (10.1 g, 22.58 mmol) and Pd (PPh 3 ) 4 (0.26 g, 0.226 mmol) synthesized in <Step 2> were flasked. After dissolving in 151 mL of Toluene under nitrogen atmosphere, 75 mL of an aqueous solution of sodium carbonate (4.8 g, 45.2 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백 색 고체의 원하는 표제 화합물 Inv A-12(9.14 g, 수율 68 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to afford the title compound Inv A-12 (9.14 g, 68% yield) as a white solid.

GC-Mass (이론치: 595.14 g/mol, 측정치: 595 g/mol)GC-Mass (Theoretical value: 595.14 g / mol, Measured value: 595 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.80~6.96(m, 4H), 6.96~7.02(m, 4H), 7.44(m, 1H), 7.66(S, 3H), 7.82~7.88(m, 4H), 7.97 (m, 1H), 8.04(m, 1H), 8.12~8.18(m, 3H), 8.70(m, 1H), 8.81(S, 1H), 8.93 (m, 2H), 9.15(m, 1H) 1 H-NMR (THF-d 8 , 500MHz) d (ppm) 6.80 ~ 6.96 (m, 4H), 6.96 ~ 7.02 (m, 4H), 7.44 (m, 1H), 7.66 (S, 3H), 7.82 ~ 7.88 (m, 4H), 7.97 (m, 1H), 8.04 (m, 1H), 8.12-8.18 (m, 3H), 8.70 (m, 1H), 8.81 (S, 1H), 8.93 (m, 2H) , 9.15 (m, 1 H)

<< 합성예Synthetic example 4> 화합물  4> Compound InvInv A-28의 합성 Synthesis of A-28

Figure 112009081810135-PAT00029
Figure 112009081810135-PAT00029

<단계 1> 화합물 5의 합성Step 1 Synthesis of Compound 5

Thianthren-1-ylboronic acid (10.2g, 39.3mmol), 2,6-Dibromopyridine(14 g, 58.9 mmol) 및 Pd(PPh3)4 (0.45 g, 0.393 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 196 ㎖와 Ethanol 98 ㎖의 혼합용매에 용해시킨 후 Sodium carbonate (6.3 g, 58.9 mmol)을 녹인 수용액 98 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Thianthren-1-ylboronic acid (10.2 g, 39.3 mmol), 2,6-Dibromopyridine (14 g, 58.9 mmol) and Pd (PPh 3 ) 4 (0.45 g, 0.393 mmol) were added to the flask and 196 mL of Toluene under nitrogen atmosphere. After dissolving in 98 mL of ethanol and solvent, 98 mL of an aqueous solution of sodium carbonate (6.3 g, 58.9 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응 종료 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크 로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 5(9.3 g, 수율 64 %)을 수득하였다.After completion of the reaction, the mixture was extracted three times with 50 ml of dichloromethane, and the extract was dried over Magnesium sulphate, filtered, and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 5 (9.3 g, yield 64%) as a white solid.

GC-Mass (이론치: 369.95 g/mol, 측정치: 369 g/mol)GC-Mass (Theoretical value: 369.95 g / mol, Measured value: 369 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv A-28의 합성 Synthesis of A-28

상기 준비예 1에서 최종 합성한 화합물(8.5 g, 24.0mmol), 상기 <단계 1>에서 합성한 화합물 5(8.9g, 24.0mmol) 및 Pd(PPh3)4 (0.28 g, 0.24 mmol)을 플라스크에 넣고 질소 분위기하에 Toluene 160 ㎖에 용해시킨 후 Sodium carbonate (5.09 g, 48.0 mmol)을 녹인 수용액 80 ㎖를 첨가하여 12시간 동안 환류 교반하였다. The compound (8.5 g, 24.0 mmol) finally synthesized in Preparation Example 1, Compound 5 (8.9 g, 24.0 mmol) and Pd (PPh 3 ) 4 (0.28 g, 0.24 mmol) synthesized in <Step 1> were flasked. After dissolving in 160 ml of Toluene under nitrogen atmosphere, 80 ml of an aqueous solution of sodium carbonate (5.09 g, 48.0 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응 종료 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv A-28(8.7 g, 수율 70 %)을 수득하였다.After completion of the reaction, the mixture was extracted three times with 50 ml of dichloromethane, and the extract was dried over Magnesium sulphate, filtered, and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv A-28 (8.7 g, yield 70%) as a white solid.

GC-Mass (이론치: 519.11 g/mol, 측정치: 519 g/mol)GC-Mass (Theoretical value: 519.11 g / mol, Measured value: 519 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.80(m, 2H), 6.89(m, 1H), 7.00~7.02(m, 3H), 7.14~7.19(m, 3H), 7.53(m, 1H), 7.82~7.88(m, 4H), 8.12(m, 2H), 8.21(m, 1H), 8.55(m, 1H), 8.93(m, 2H), 9.66(S, 1H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.80 (m, 2H), 6.89 (m, 1H), 7.00-7.02 (m, 3H), 7.14-7.19 (m, 3H), 7.53 ( m, 1H), 7.82-7.88 (m, 4H), 8.12 (m, 2H), 8.21 (m, 1H), 8.55 (m, 1H), 8.93 (m, 2H), 9.66 (S, 1H).

<< 합성예Synthetic example 5> 화합물  5> Compound InvInv A-29의 합성 Synthesis of A-29

Figure 112009081810135-PAT00030
Figure 112009081810135-PAT00030

<단계 1> 화합물 6의 합성Step 1 Synthesis of Compound 6

Thianthren-1-ylboronic acid(11.3 g, 43.3mmol), 2-Bromo-5-iodopyridine(14 g, 64.9 mmol) 및 Pd(PPh3)4 (0.50 g, 0.433 mmol)을 플라스크에 넣고 질소 분위기하에 Toluene 217 ㎖와 Ethanol 108 ㎖의 혼합용매에 용해시킨 후 Sodium carbonate (6.9 g, 64.9 mmol)을 녹인 수용액 108 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Thianthren-1-ylboronic acid (11.3 g, 43.3 mmol), 2-Bromo-5-iodopyridine (14 g, 64.9 mmol) and Pd (PPh 3 ) 4 (0.50 g, 0.433 mmol) were placed in a flask and toluene under nitrogen atmosphere. After dissolving in a mixed solvent of 217 mL and 108 mL of ethanol, 108 mL of an aqueous solution of sodium carbonate (6.9 g, 64.9 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 화합물 6(10.4 g, 수율 65 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to give compound 6 (10.4 g, yield 65%) as a white solid.

GC-Mass (이론치: 370.94 g/mol, 측정치: 370 g/mol)GC-Mass (Theoretical value: 370.94 g / mol, Measured value: 370 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv A-29의 합성 Synthesis of A-29

상기 준비예 1에서 최종 합성한 화합물(8.5 g, 24.0 mmol), 상기 <단계 1>에서 합성한 화합물 6(8.9g, 24.0mmol) 및 Pd(PPh3)4 (0.28 g, 0.24 mmol)을 플라스크 에 넣고 질소 분위기 하에 Toluene 160 ㎖에 용해시킨 후 Sodium carbonate (5.09 g, 48.0 mmol)을 녹인 수용액 80 ㎖를 첨가하여 12시간 동안 환류 교반하였다. The final compound (8.5 g, 24.0 mmol) synthesized in Preparation Example 1, the compound 6 (8.9 g, 24.0 mmol) and Pd (PPh 3 ) 4 (0.28 g, 0.24 mmol) synthesized in the <step 1> flask It was dissolved in 160 ml of Toluene under a nitrogen atmosphere, and 80 ml of an aqueous solution of sodium carbonate (5.09 g, 48.0 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv A-29(8.5 g, 수율 68 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to afford the title compound Inv A-29 (8.5 g, yield 68%) as a white solid.

GC-Mass (이론치: 519.11 g/mol, 측정치: 519 g/mol)GC-Mass (Theoretical value: 519.11 g / mol, Measured value: 519 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.80~6.96(m, 4H), 6.96~7.02(m, 4H), 7.60(m, 1H), 7.69(m, 1H), 7.82~7.88(m, 4H), 8.12(m, 2H), 8.21(m, 1H), 8.55(m, 1H), 8.78(m, 1H), 8.93(m, 2H), 9.66(S, 1H). 1 H-NMR (THF-d 8 , 500MHz) d (ppm) 6.80 ~ 6.96 (m, 4H), 6.96 ~ 7.02 (m, 4H), 7.60 (m, 1H), 7.69 (m, 1H), 7.82 ~ 7.88 (m, 4H), 8.12 (m, 2H), 8.21 (m, 1H), 8.55 (m, 1H), 8.78 (m, 1H), 8.93 (m, 2H), 9.66 (S, 1H).

<< 합성예Synthetic example 6> 화합물  6> Compound InvInv A-30의 합성 Synthesis of A-30

Figure 112009081810135-PAT00031
Figure 112009081810135-PAT00031

<단계 1> 화합물 7의 합성Step 1 Synthesis of Compound 7

Thianthren-1-ylboronic acid(10.6 g, 40.6mmol), 5-Bromo-2-chloropyrimidine(7.9 g, 40.6 mmol) 및 Pd(PPh3)4 (0.47 g, 0.406 mmol)을 플라스 크에 넣고 질소 분위기 하에 Toluene 203 ㎖에 용해시킨 후 Sodium carbonate (6.9 g, 64.9 mmol)을 녹인 수용액 102 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Thianthren-1-ylboronic acid (10.6 g, 40.6 mmol), 5-Bromo-2-chloropyrimidine (7.9 g, 40.6 mmol) and Pd (PPh 3 ) 4 (0.47 g, 0.406 mmol) were placed in a flask under nitrogen atmosphere. After dissolving in 203 mL of toluene, 102 mL of an aqueous solution of sodium carbonate (6.9 g, 64.9 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 화합물 7(9.32 g, 수율 70 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to give compound 7 (9.32 g, yield 70%) as a white solid.

GC-Mass (이론치: 327.99 g/mol, 측정치: 328 g/mol)GC-Mass (Theoretical value: 327.99 g / mol, Measured value: 328 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv A-30의 합성 Synthesis of A-30

상기 준비예 1에서 최종 합성한 화합물(8.5 g, 24.0mmol), 상기 <단계 1>에서 합성한 화합물 7(7.87g, 24.0mmol) 및 Pd(PPh3)4 (0.28 g, 0.24 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 160 ㎖에 용해시킨 후 Sodium carbonate (5.09 g, 48.0 mmol)을 녹인 수용액 80 ㎖를 첨가하여 이틀 동안 환류 교반하였다. The compound (8.5 g, 24.0 mmol) finally synthesized in Preparation Example 1, Compound 7 (7.87 g, 24.0 mmol) and Pd (PPh 3 ) 4 (0.28 g, 0.24 mmol) synthesized in <Step 1> were flasked. It was dissolved in 160 ml of Toluene under nitrogen atmosphere, and 80 ml of an aqueous solution of sodium carbonate (5.09 g, 48.0 mmol) was added thereto, followed by stirring under reflux for two days.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv A-30(8.5 g, 수율 68 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv A-30 (8.5 g, 68% yield) as a white solid.

GC-Mass (이론치: 520.11 g/mol, 측정치: 520 g/mol)GC-Mass (Theoretical value: 520.11 g / mol, Measured value: 520 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.80~6.86(m, 3H), 6.96~7.02(m, 4H), 7.82~7.88(m, 4H), 8.04(m, 1H), 8.12~8.18(m, 3H), 8.84(m, 2H), 8.93(m, 2H), 9.15(S, 1H) 1 H-NMR (THF-d 8 , 500MHz) d (ppm) 6.80 ~ 6.86 (m, 3H), 6.96 ~ 7.02 (m, 4H), 7.82 ~ 7.88 (m, 4H), 8.04 (m, 1H), 8.12-8.18 (m, 3H), 8.84 (m, 2H), 8.93 (m, 2H), 9.15 (S, 1H)

<< 합성예Synthetic example 7> 화합물  7> Compound InvInv B-2의 합성 Synthesis of B-2

Figure 112009081810135-PAT00032
Figure 112009081810135-PAT00032

<단계 1> 화합물 8의 합성Step 1 Synthesis of Compound 8

Phenoxathiin-4-ylboronic acid(8.8g, 39.3mmol), 1-bromo-3-Iodobenzene (16.7 g, 58.9 mmol) 및 Pd(PPh3)4 (0.45 g, 0.393 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 196 ㎖와 Ethanol 98 ㎖의 혼합용매에 용해시킨 후 Potassium carbonate (8.1 g, 58.9 mmol)을 녹인 수용액 98 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Phenoxathiin-4-ylboronic acid (8.8g, 39.3mmol), 1-bromo-3-Iodobenzene (16.7 g, 58.9 mmol) and Pd (PPh 3 ) 4 (0.45 g, 0.393 mmol) were added to the flask and toluene under nitrogen atmosphere. After dissolving in a mixed solvent of 196 mL and 98 mL of Ethanol, 98 mL of an aqueous solution of Potassium carbonate (8.1 g, 58.9 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 8(9.3 g, 수율 67 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 8 (9.3 g, yield 67%) as a white solid.

GC-Mass (이론치: 353.97 g/mol, 측정치: 353 g/mol)GC-Mass (Theoretical value: 353.97 g / mol, Measured value: 353 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv B-2의 합성 Synthesis of B-2

상기 준비예 1에서 최종 합성한 화합물(7.12 g, 20.09mmol), 상기 <단계 1>에서 합성한 화합물 8(7.1g, 20.09mmol) 및 Pd(PPh3)4 (0.23 g, 0.201 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 133 ㎖에 용해시킨 후 Potassium carbonate (5.55 g, 40.2 mmol)을 녹인 수용액 67 ㎖를 첨가하여 12시간 동안 환류 교반하였다. The compound (7.12 g, 20.09 mmol) finally synthesized in Preparation Example 1, flask 8 (7.1 g, 20.09 mmol) and Pd (PPh 3 ) 4 (0.23 g, 0.201 mmol) synthesized in <Step 1> were flasked. It was dissolved in 133 mL of Toluene under nitrogen atmosphere, and 67 mL of an aqueous solution of Potassium carbonate (5.55 g, 40.2 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv B-2(6.6 g, 수율 65 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv B-2 (6.6 g, 65% yield) as a white solid.

GC-Mass (이론치: 502.14 g/mol, 측정치: 502 g/mol)GC-Mass (Theoretical value: 502.14 g / mol, Measured value: 502 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.72(m, 1H), 6.84(m, 1H), 6.96(m, 1H), 7.12~7.18(m, 4H), 7.38~7.44(m, 3H), 7.70(S, 1H), 7.82~7.88(m, 4H), 8.04(m, 1H), 8.12 ~ 8.18(m, 3H), 8.93(m, 2H), 9.15(S, 1H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.12-7.18 (m, 4H), 7.38-7.44 ( m, 3H), 7.70 (S, 1H), 7.82-7.88 (m, 4H), 8.04 (m, 1H), 8.12-8.18 (m, 3H), 8.93 (m, 2H), 9.15 (S, 1H) .

<< 합성예Synthetic example 8> 화합물  8> Compound InvInv B-4의 합성 Synthesis of B-4

Figure 112009081810135-PAT00033
Figure 112009081810135-PAT00033

<단계 1> 화합물 9의 합성Step 1 Synthesis of Compound 9

Phenoxathiin-4-ylboronic acid(8.8g, 39.3mmol), 1,3-Dibromo-5-fluorobenzene(15 g, 58.9 mmol) 및 Pd(PPh3)4 (0.45 g, 0.393 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 196 ㎖와 Ethanol 98 ㎖의 혼합용매에 용해시킨 후 Sodium carbonate (6.3 g, 58.9 mmol)을 녹인 수용액 98 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Phenoxathiin-4-ylboronic acid (8.8 g, 39.3 mmol), 1,3-Dibromo-5-fluorobenzene (15 g, 58.9 mmol) and Pd (PPh 3 ) 4 (0.45 g, 0.393 mmol) were added to the flask and nitrogen atmosphere. After dissolving in a mixed solvent of 196 ml of Toluene and 98 ml of ethanol, 98 ml of an aqueous solution of sodium carbonate (6.3 g, 58.9 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 9(9.4 g, 수율 64 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 9 (9.4 g, 64% yield) as a white solid.

GC-Mass (이론치: 371.96 g/mol, 측정치: 371 g/mol)GC-Mass (Theoretical value: 371.96 g / mol, Measured value: 371 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv B-4의 합성 Synthesis of B-4

상기 준비예 1에서 최종 합성한 화합물(7.5 g, 21.17mmol), 상기 <단계 1>에서 합성한 화합물 9(7.2g, 19.25mmol) 및 Pd(PPh3)4 (0.22 g, 0.193 mmol)을 플라스 크에 넣고 질소 분위기 하에 Toluene 128 ㎖에 용해시킨 후 Sodium carbonate (4.1 g, 38.5 mmol)을 녹인 수용액 64 ㎖를 첨가하여 12시간 동안 환류 교반하였다. The final compound (7.5 g, 21.17 mmol) synthesized in Preparation Example 1, compound 9 (7.2 g, 19.25 mmol) and Pd (PPh 3 ) 4 (0.22 g, 0.193 mmol) synthesized in <Step 1> were then flasked. After dissolving in 128 ml of Toluene under nitrogen atmosphere, 64 ml of an aqueous solution of sodium carbonate (4.1 g, 38.5 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv B-4(7.7 g, 수율 77 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv B-4 (7.7 g, 77% yield) as a white solid.

GC-Mass (이론치: 520.13 g/mol, 측정치: 520 g/mol)GC-Mass (Theoretical value: 520.13 g / mol, Measured value: 520 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.72(m, 1H), 6.84(m, 1H), 6.96 (m, 1H), 7.15(m, 2H), 7.47(S, 1H), 7.82~7.88(m, 4H), 8.04(m, 1H), 8.12~8.18(m, 3H), 8.93(m, 2H), 9.15(S, 1H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.15 (m, 2H), 7.47 (S, 1H) , 7.82-7.88 (m, 4H), 8.04 (m, 1H), 8.12-8.18 (m, 3H), 8.93 (m, 2H), 9.15 (S, 1H).

<< 합성예Synthetic example 9> 화합물  9> Compound InvInv B-12의 합성 Synthesis of B-12

Figure 112009081810135-PAT00034
Figure 112009081810135-PAT00034

<단계 1> 화합물 10의 합성Step 1 Synthesis of Compound 10

Phenoxathiin-4-ylboronic acid(5.1 g, 22.58 mmol), 1,3,5-Tribromobenzene (7.1 g, 22.58 mmol) 및 Pd(PPh3)4 (0.26 g, 0.226 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 151 ㎖에 용해시킨 후 Sodium carbonate (4.8 g, 45.2 mmol)을 녹인 수용액 75 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Phenoxathiin-4-ylboronic acid (5.1 g, 22.58 mmol), 1,3,5-Tribromobenzene (7.1 g, 22.58 mmol) and Pd (PPh 3 ) 4 (0.26 g, 0.226 mmol) were added to the flask and toluene under nitrogen atmosphere. After dissolving in 151 mL, 75 mL of an aqueous solution of sodium carbonate (4.8 g, 45.2 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 10(7.8 g, 수율 80 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 10 (7.8 g, yield 80%) as a white solid.

GC-Mass (이론치: 431.88 g/mol, 측정치: 432 g/mol)GC-Mass (Theoretical value: 431.88 g / mol, Measured value: 432 g / mol)

<단계 2> 화합물 11의 합성Step 2 Synthesis of Compound 11

상기 <단계 1>에서 합성한 화합물 10(19.4g, 44.9mmol), 3-Pyridineboronic acid(5.52 g, 44.9 mmol) 및 Pd(PPh3)4 (0.52 g, 0.449 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 225 ㎖와 Ethanol 112 ㎖의 혼합용매에 용해시킨 후 Sodium carbonate (6.3 g, 58.9 mmol)을 녹인 수용액 112 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Compound 10 (19.4 g, 44.9 mmol), 3-Pyridineboronic acid (5.52 g, 44.9 mmol) and Pd (PPh 3 ) 4 (0.52 g, 0.449 mmol) synthesized in <Step 1> were placed in a flask under nitrogen atmosphere. After dissolving in a mixed solvent of 225 ml of toluene and 112 ml of ethanol, 112 ml of an aqueous solution of sodium carbonate (6.3 g, 58.9 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백 색 고체의 화합물 11(12.8 g, 수율 66 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give the compound 11 (12.8 g, 66% yield) of a white solid.

GC-Mass (이론치: 431 g/mol, 측정치: 431 g/mol)GC-Mass (Theoretical value: 431 g / mol, Measured value: 431 g / mol)

<단계 3> 화합물 B-12의 합성Step 3 Synthesis of Compound B-12

상기 준비예 1에서 최종 합성한 화합물(8.0 g, 22.58mmol), 상기 <단계 2>에서 합성한 화합물 11(9.7g, 22.58mmol) 및 Pd(PPh3)4 (0.26 g, 0.226 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 151 ㎖에 용해시킨 후 Sodium carbonate (4.8 g, 45.2 mmol)을 녹인 수용액 75 ml를 첨가하여 12시간 동안 환류 교반하였다. The compound (8.0 g, 22.58 mmol) finally synthesized in Preparation Example 1, the compound 11 (9.7 g, 22.58 mmol) and Pd (PPh 3 ) 4 (0.26 g, 0.226 mmol) synthesized in <Step 2> were flasked. After dissolving in 151 ml of Toluene under nitrogen atmosphere, 75 ml of an aqueous solution of sodium carbonate (4.8 g, 45.2 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv B-12(8.4 g, 수율 64 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv B-12 (8.4 g, 64% yield) as a white solid.

GC-Mass (이론치: 579.17 g/mol, 측정치: 579 g/mol)GC-Mass (Theoretical value: 579.17 g / mol, Measured value: 579 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.72(m, 1H), 6.84(m, 1H), 6.96(m, 1H), 7.12~7.18(m, 4H), 7.44(m, 1H), 7.66(S, 3H), 7.82~7.88(m, 4H), 7.97 (m, 1H), 8.04(m, 1H), 8.12~8.18(m, 3H), 8.70(m, 1H), 8.81(S, 1H), 8.93 (m, 2H), 9.15(m, 1H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.12 to 7.18 (m, 4H), 7.44 (m, 1H), 7.66 (S, 3H), 7.82-7.88 (m, 4H), 7.97 (m, 1H), 8.04 (m, 1H), 8.12-8.18 (m, 3H), 8.70 (m, 1H), 8.81 (S, 1 H), 8.93 (m, 2 H), 9.15 (m, 1 H).

<< 합성예Synthetic example 10> 화합물  10> Compound InvInv B-28의 합성 Synthesis of B-28

Figure 112009081810135-PAT00035
Figure 112009081810135-PAT00035

<단계 1> 화합물 12의 합성Step 1 Synthesis of Compound 12

Phenoxathiin-4-ylboronic acid(9.6g, 39.3mmol), 2,6-Dibromopyridine(14 g, 58.9 mmol), 및 Pd(PPh3)4 (0.45 g, 0.393 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 196 ㎖와 Ethanol 98 ㎖의 혼합용매에 용해시킨 후 Sodium carbonate (6.3 g, 58.9 mmol)을 녹인 수용액 98 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Phenoxathiin-4-ylboronic acid (9.6 g, 39.3 mmol), 2,6-Dibromopyridine (14 g, 58.9 mmol), and Pd (PPh 3 ) 4 (0.45 g, 0.393 mmol) were placed in a flask and Toluene 196 under nitrogen atmosphere. After dissolving in a mixed solvent of ㎖ and Ethanol 98 ㎖ 98 ml of an aqueous solution of sodium carbonate (6.3 g, 58.9 mmol) was added and stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 12(9.3 g, 수율 67 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 12 (9.3 g, yield 67%) as a white solid.

GC-Mass (이론치: 353.97 g/mol, 측정치: 354 g/mol)GC-Mass (Theoretical value: 353.97 g / mol, Measured value: 354 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv B-28의 합성 Synthesis of B-28

상기 준비예 1에서 최종 합성한 화합물(8.5 g, 24.0mmol), 상기 <단계 1>에 서 합성한 화합물 12(8.5g, 24.0mmol) 및 Pd(PPh3)4 (0.28 g, 0.24 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 160 ㎖에 용해시킨 후 Sodium carbonate (5.09 g, 48.0 mmol)을 녹인 수용액 80 ㎖를 첨가하여 12시간 동안 환류 교반하였다. The compound (8.5 g, 24.0 mmol) finally synthesized in Preparation Example 1, Compound 12 (8.5 g, 24.0 mmol) and Pd (PPh 3 ) 4 (0.28 g, 0.24 mmol) synthesized in <Step 1> were prepared The mixture was dissolved in 160 ml of Toluene under a nitrogen atmosphere, and 80 ml of an aqueous solution of sodium carbonate (5.09 g, 48.0 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv B-28(8.7 g, 수율 72 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv B-28 (8.7 g, 72% yield) as a white solid.

GC-Mass (이론치: 503.13 g/mol, 측정치: 503 g/mol)GC-Mass (Theoretical value: 503.13 g / mol, Measured value: 503 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.72(m, 1H), 6.87(m, 1H), 6.96(m, 1H), 7.14~7.19(m, 6H), 7.82~7.88(m, 4H), 8.12(m, 2H), 8.21(m, 1H), 8.55(m, 1H), 8.64(m, 1H), 8.93(m, 2H), 9.66(S, 1H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.72 (m, 1H), 6.87 (m, 1H), 6.96 (m, 1H), 7.14-7.19 (m, 6H), 7.82-7.88 ( m, 4H), 8.12 (m, 2H), 8.21 (m, 1H), 8.55 (m, 1H), 8.64 (m, 1H), 8.93 (m, 2H), 9.66 (S, 1H).

<< 합성예Synthetic example 11> 화합물  11> Compound InvInv B-29의 합성 Synthesis of B-29

Figure 112009081810135-PAT00036
Figure 112009081810135-PAT00036

<단계 1> 화합물 13의 합성Step 1 Synthesis of Compound 13

Phenoxathiin-4-ylboronic acid(10.8g, 43.3mmol), 2-Bromo-5-iodopyridine (14 g, 64.9 mmol) 및 Pd(PPh3)4 (0.50 g, 0.433 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 217 ㎖와 Ethanol 108 ㎖의 혼합용매에 용해시킨 후 Sodium carbonate (6.9 g, 64.9 mmol)을 녹인 수용액 108 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Phenoxathiin-4-ylboronic acid (10.8 g, 43.3 mmol), 2-Bromo-5-iodopyridine (14 g, 64.9 mmol) and Pd (PPh 3 ) 4 (0.50 g, 0.433 mmol) were added to the flask and toluene under nitrogen atmosphere. After dissolving in a mixed solvent of 217 mL and 108 mL of ethanol, 108 mL of an aqueous solution of sodium carbonate (6.9 g, 64.9 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 화합물 13(10.8 g, 수율 70 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to give compound 13 (10.8 g, yield 70%) as a white solid.

GC-Mass (이론치: 354.97 g/mol, 측정치: 355 g/mol)GC-Mass (Theoretical value: 354.97 g / mol, Measured value: 355 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv B-29의 합성 Synthesis of B-29

상기 준비예 1에서 최종 합성한 화합물(8.5 g, 24.0mmol), 상기 <단계 1>에서 합성한 화합물 13(8.5g, 24.0mmol), 및 Pd(PPh3)4 (0.28 g, 0.24 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 160 ㎖에 용해시킨 후 Sodium carbonate (5.09 g, 48.0 mmol)을 녹인 수용액 80 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Final compound (8.5 g, 24.0 mmol) synthesized in Preparation Example 1, Compound 13 (8.5 g, 24.0 mmol), and Pd (PPh 3 ) 4 (0.28 g, 0.24 mmol) synthesized in <Step 1> were prepared The mixture was dissolved in 160 ml of Toluene under a nitrogen atmosphere, and 80 ml of an aqueous solution of sodium carbonate (5.09 g, 48.0 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카 겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv B-29(8.7 g, 수율 72 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to afford the title compound Inv B-29 (8.7 g, 72% yield) as a white solid.

GC-Mass (이론치: 503.13 g/mol, 측정치: 503 g/mol)GC-Mass (Theoretical value: 503.13 g / mol, Measured value: 503 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.72(m, 1H), 6.84(m, 1H), 6.96(m, 1H), 7.12~7.18(m, 4H), 7.60(m, 1H), 7.69(m, 1H), 7.82~7.88(m, 4H), 8.12(m, 2H), 8.21(m, 1H), 8.55(m, 1H), 8.78(m, 1H), 8.93(m, 2H), 9.66(S, 1H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.12 to 7.18 (m, 4H), 7.60 (m, 1H), 7.69 (m, 1H), 7.82-7.88 (m, 4H), 8.12 (m, 2H), 8.21 (m, 1H), 8.55 (m, 1H), 8.78 (m, 1H), 8.93 (m , 2H), 9.66 (S, 1H).

<< 합성예Synthetic example 12> 화합물  12> Compound InvInv B-30의 합성 Synthesis of B-30

Figure 112009081810135-PAT00037
Figure 112009081810135-PAT00037

<단계 1> 화합물 14의 합성Step 1 Synthesis of Compound 14

Phenoxathiin-4-ylboronic acid(9.9 g, 40.6mmol), 5-Bromo-2-chloropyrimidine(7.9 g, 40.6 mmol) 및 Pd(PPh3)4 (0.47 g, 0.406 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 203 ㎖에 용해시킨 후 Sodium carbonate (6.9 g, 64.9 mmol)을 녹인 수용액 102 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Phenoxathiin-4-ylboronic acid (9.9 g, 40.6 mmol), 5-Bromo-2-chloropyrimidine (7.9 g, 40.6 mmol) and Pd (PPh 3 ) 4 (0.47 g, 0.406 mmol) were placed in a flask and toluene under nitrogen atmosphere. After dissolving in 203 mL, 102 mL of an aqueous solution of sodium carbonate (6.9 g, 64.9 mmol) was added thereto, followed by stirring under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카 겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 화합물 14(9.5 g, 수율 75 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to give compound 14 (9.5 g, yield 75%) as a white solid.

GC-Mass (이론치: 312.02 g/mol, 측정치: 312 g/mol)GC-Mass (Theoretical value: 312.02 g / mol, Measured value: 312 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv B-30의 합성 Synthesis of B-30

상기 준비예 1에서 최종 합성한 화합물(8.5 g, 24.0mmol), 상기 <단계 1>에서 합성한 화합물 14(7.5 g, 24.0mmol) 및 Pd(PPh3)4 (0.28 g, 0.24 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 160 ㎖에 용해시킨 후 Sodium Carbonate (5.09 g, 48.0 mmol)을 녹인 수용액 80 ㎖를 첨가하여 이틀동안 환류 교반하였다. The compound (8.5 g, 24.0 mmol) finally synthesized in Preparation Example 1, the compound 14 (7.5 g, 24.0 mmol) and Pd (PPh 3 ) 4 (0.28 g, 0.24 mmol) synthesized in <Step 1> were flasked. It was dissolved in 160 ml of Toluene under a nitrogen atmosphere, and 80 ml of an aqueous solution of sodium carbonate (5.09 g, 48.0 mmol) was added thereto, followed by stirring under reflux for two days.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv B-30(8.7 g, 수율 72 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to afford the title compound Inv B-30 (8.7 g, 72% yield) as a white solid.

GC-Mass (이론치: 504.13 g/mol, 측정치: 504 g/mol)GC-Mass (Theoretical value: 504.13 g / mol, Measured value: 504 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.12~7.18(m, 4H), 7.82~7 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.12-7.18 (m, 4H), 7.82-7

<< 준비예Preparation 2>  2> triphenylenetriphenylene -2,7--2,7- diyldiyl bisbis (( trifluoromethanesulfonatetrifluoromethanesulfonate )의 합성 ) Synthesis

<< 단계 1> 화합물 15(3,3'-Step 1> Compound 15 (3,3'- dimethoxydimethoxy -o--o- terphenylterphenyl )의 합성) Synthesis

Figure 112009081810135-PAT00038
Figure 112009081810135-PAT00038

1,2-dibromobenzene (50 g, 214 mmol), 3-methoxyphenylboronic acid(65.1 g, 428 mmol) 및 Pd(PPh3)4 (4.95 g, 4.28 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 1.4 L 에 용해시킨 후 Sodium carbonate (118.2 g, 856 mmol)을 녹인 수용액 1.2 L 를 첨가하여 12시간 동안 환류 교반하였다. 1,2-dibromobenzene (50 g, 214 mmol), 3-methoxyphenylboronic acid (65.1 g, 428 mmol) and Pd (PPh 3 ) 4 (4.95 g, 4.28 mmol) were added to the flask and dissolved in 1.4 L of Toluene under nitrogen atmosphere. Then, 1.2 L of an aqueous solution of sodium carbonate (118.2 g, 856 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 200 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 화합물 15 (43.5 g, 수율 70 %)을 수득하였다.After completion of the reaction, the mixture was extracted three times with 200 ml of dichloromethane, and the extract was dried over Magnesium sulphate, filtered, and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give compound 15 (43.5 g, yield 70%) as a white solid.

GC-Mass (이론치: 290.13 g/mol, 측정치: 290 g/mol) GC-Mass (Theoretical value: 290.13 g / mol, Measured value: 290 g / mol)

<단계 2> 화합물 16(2,7-<Step 2> Compound 16 (2,7- dimethoxytriphenylenedimethoxytriphenylene )의 합성) Synthesis

Figure 112009081810135-PAT00039
Figure 112009081810135-PAT00039

상기 <단계 1>에서 얻어진 화합물 15 (40 g, 137 mmol)를 플라스크에 넣고 질소 분위기 하에, 디클로로메탄 1 L 에 용해시킨 다음 Iron(III) chloride ( 44.4 g, 274 mmol)을 넣고 상온에서 12시간 동안 교반하였다. 이후, 2 당량의 iron(III) choloride를 추가로 첨가한 뒤, 한시간 더 교반하고 메틸알콜과 물을 1:1의 비율로 1L 첨가하였다.Compound 15 (40 g, 137 mmol) obtained in <Step 1> was placed in a flask, dissolved in 1 L of dichloromethane under a nitrogen atmosphere, and then Iron (III) chloride (44.4 g, 274 mmol) was added thereto at room temperature for 12 hours. Was stirred. Thereafter, 2 equivalents of iron (III) choloride were further added, followed by stirring for an hour, and 1 liter of methyl alcohol and water were added at a ratio of 1: 1.

반응이 종결된 후, 유기층을 분리하여 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 2 : 3 (v:v))로 분리하여 31.6 g 의 생성물을 얻고 이를 아세토니트릴 600 ml에 재결정하여 옅은 노란색 고체의 화합물 16(28 g, 수율 70 %)을 수득하였다.After the reaction was completed, the organic layer was separated, dried over Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was separated by silica gel column chromatography (n-Hexane: Dichloromethane = 2: 3 (v: v)) to give 31.6 g of product which was recrystallized in 600 ml of acetonitrile to give a pale yellow solid compound 16 (28 g, Yield 70%) was obtained.

GC-Mass (이론치: 288.12 g/mol, 측정치: 288 g/mol), GC-Mass (Theoretical value: 288.12 g / mol, Measured value: 288 g / mol),

<단계 3> 화합물 17(2,7-<Step 3> Compound 17 (2,7- dihydroxytriphenylenedihydroxytriphenylene )의 합성) Synthesis

Figure 112009081810135-PAT00040
Figure 112009081810135-PAT00040

상기 <단계 2>에서 얻어진 화합물 16(25 g, 86 mmol) 및 pyridine hydrochloride (100g, 86 mmol)을 플라스크에 넣고 질소 분위기 하에서 220℃에서 90 분간 환류 교반하였다. 반응이 종결된 후, 조 산물을 과량의 물로 세척하여 화합물 17(20g, 수율 88 %)을 수득하였다.Compound 16 (25 g, 86 mmol) and pyridine hydrochloride (100 g, 86 mmol) obtained in <Step 2> were placed in a flask and stirred under reflux for 90 minutes at 220 ° C. under a nitrogen atmosphere. After the reaction was completed, the crude product was washed with excess water to give compound 17 (20 g, yield 88%).

GC-Mass (이론치: 260.08 g/mol, 측정치: 260 g/mol), GC-Mass (Theoretical value: 260.08 g / mol, Measured value: 260 g / mol),

<단계 4> 화합물 18(Step 4 Compound 18 ( triphenylenetriphenylene -2,7--2,7- diyldiyl bisbis (( trifluoromethanesulfonatetrifluoromethanesulfonate ))의 합성Synthesis of))

Figure 112009081810135-PAT00041
Figure 112009081810135-PAT00041

상기 <단계 3>에서 얻어진 화합물 17(20 g, 77 mmol)을 플라스크에 넣고 질소 분위기 하에서 pyridine 385 ml에 용해하여 0℃에서 교반하였다. 여기에 trifluoromethanesylfonyl anhydride (43.5 g, 154 mmol)를 천천히 한방울씩 적가 한 다음 상온에서 12시간 동안 교반하였다. Compound 17 (20 g, 77 mmol) obtained in <Step 3> was placed in a flask, dissolved in 385 ml of pyridine under a nitrogen atmosphere, and stirred at 0 ° C. Trifluoromethanesylfonyl anhydride (43.5 g, 154 mmol) was slowly added dropwise thereto, followed by stirring at room temperature for 12 hours.

반응이 종결된 후, 반응물을 감압 농축한 뒤 얻어진 고체를 플라스크에 넣고 메틸알콜 500 ml를 첨가하여 1시간 동안 교반 및 여과하여 백색 고체의 혼합물을 35 g 얻었다. 조 산물을 헥산/디클로로메탄으로 재결정하여 백색 고체의 화합물 18(28g, 수율: 68 %)을 수득하였다.After the reaction was completed, the reaction product was concentrated under reduced pressure, the solid obtained was placed in a flask, and 500 ml of methyl alcohol was added thereto. The mixture was stirred and filtered for 1 hour to obtain 35 g of a mixture of white solids. The crude product was recrystallized from hexane / dichloromethane to give compound 18 (28 g, yield: 68%) as a white solid.

GC-Mass (이론치: 523.98 g/mol, 측정치: 524 g/mol), GC-Mass (Theoretical value: 523.98 g / mol, Measured value: 524 g / mol),

1H-NMR (THF-d8, 500MHz) d (ppm) 7.83 ~ 7.85(m, 4H), 8.07(m, 2H), 8.52(m, 2H), 9.0(m, 2H) 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 7.83 to 7.85 (m, 4H), 8.07 (m, 2H), 8.52 (m, 2H), 9.0 (m, 2H)

<< 준비예Preparation 3> 4,4,5,5- 3> 4,4,5,5- tetramethyltetramethyl -2-(3-(-2- (3- ( thianthrenthianthren -1--One- ylyl )) phenylphenyl )-1,3,2-) -1,3,2- dioxaborolane 의of dioxaborolane 합성 synthesis

Figure 112009081810135-PAT00042
Figure 112009081810135-PAT00042

상기 합성예 1의 <단계 1>에서 얻어진 화합물 1(60.7 g, 164 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (83 g, 327 mmol), Pd(dffp)2Cl2 (4.08 g, 4.92 mmol) 및 potassium acetate (48 g, 490 mmol)을 플라스크에 넣고 질소 분위기 하에 1,4-dioxane 810 ㎖에 용해시킨 다음 12시간 동안 환류 교반하였다. Compound 1 (60.7 g, 164 mmol) obtained in <Step 1> of Synthesis Example 1, 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi ( 1,3,2-dioxaborolane) (83 g, 327 mmol), Pd (dffp) 2 Cl 2 (4.08 g, 4.92 mmol) and potassium acetate (48 g, 490 mmol) were added to the flask and 1,4 under nitrogen atmosphere. It was dissolved in 810 ml of -dioxane and stirred under reflux for 12 hours.

반응이 종결된 후 얼음물 400 ml를 첨가하고 디클로로메탄 50 ml로 3회 추출 한 다음 얻어진 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 표제 화합물(54.8 g, 수율 80 %)을 수득하였다.After the reaction was completed, 400 ml of iced water was added, extracted three times with 50 ml of dichloromethane, and the obtained extract was dried with excess Magnesium sulphate, filtered, and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give the title compound (54.8 g, yield 80%) as a white solid.

GC-Mass (이론치: 418.12 g/mol, 측정치: 418 g/mol). GC-Mass (Theoretical value: 418.12 g / mol, Measured value: 418 g / mol).

1H-NMR (THF-d8, 500MHz) d (ppm) 1.26(S, 12H), 6.80 ~ 6.86 (m, 3H), 6.96 ~ 7.02(m, 4H) 7.2(m, 1H), 7.3(m, 1H), 7.5(m, 2H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 1.26 (S, 12H), 6.80 to 6.86 (m, 3H), 6.96 to 7.02 (m, 4H) 7.2 (m, 1H), 7.3 (m , 1H), 7.5 (m, 2H).

<< 준비예Preparation 4> 4,4,5,5- 4> 4,4,5,5- tetramethyltetramethyl -2-(3-(-2- (3- ( phenoxathiinphenoxathiin -4--4- ylyl )) phenylphenyl )-1,3,2-) -1,3,2- dioxaborolane 의of dioxaborolane 합성 synthesis

Figure 112009081810135-PAT00043
Figure 112009081810135-PAT00043

상기 합성예 7의 <단계 1>에서 얻어진 화합물 8(58 g, 164 mmol), 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (83 g, 327 mmol), Pd(dffp)2Cl2 (4.08 g, 4.92 mmol) 및 potassium acetate (48 g, 490 mmol)을 플라스크에 넣고 질소 분위기 하에 1,4-dioxane 810 ㎖에 용해시킨 다음 12시간 동안 환류 교반하였다. Compound 8 (58 g, 164 mmol) obtained in <Step 1> of Synthesis Example 7, 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi ( 1,3,2-dioxaborolane) (83 g, 327 mmol), Pd (dffp) 2Cl2 (4.08 g, 4.92 mmol) and potassium acetate (48 g, 490 mmol) were added to the flask and 1,4-dioxane under nitrogen atmosphere. It was dissolved in 810 mL and then stirred at reflux for 12 hours.

반응이 종결된 후 얼음물 400 ml를 첨가하고 디클로로메탄 50 ml로 3회 추출 한 다음 얻어진 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 표제 화합물(49.4 g, 수 율 68 %)을 수득하였다.After the reaction was completed, 400 ml of iced water was added, extracted three times with 50 ml of dichloromethane, and the obtained extract was dried with excess Magnesium sulphate, filtered, and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to give the title compound (49.4 g, yield 68%) as a white solid.

GC-Mass (이론치: 402.12 g/mol, 측정치: 402 g/mol) GC-Mass (Theoretical value: 402.12 g / mol, Measured value: 402 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 1.26 (S, 12H), 6.72(m, 1H), 6.84(m, 1H), 6.96(m, 1H), 7.12 ~ 7.20(m, 5H), 7.3(m, 1H), 7.5 (m, 2H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 1.26 (S, 12H), 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.12 to 7.20 (m, 5H), 7.3 (m, 1 H), 7.5 (m, 2H).

<< 합성예Synthetic example 13> 화합물  13> Compound InvInv G-2의 합성 Synthesis of G-2

Figure 112009081810135-PAT00044
Figure 112009081810135-PAT00044

<단계 1> 화합물 19의 합성Step 1 Synthesis of Compound 19

상기 준비예 2에서 최종 합성한 화합물 18 (11 g, 21 mmol), phenylboronic acid (2.6 g, 21 mmol) 및 Pd(PPh3)4 (0.24 g, 0.21 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 140 ㎖에 용해시킨 후 Sodium carbonate (4.4 g, 31.5 mmol)을 녹인 수용액 70 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Compound 18 (11 g, 21 mmol), phenylboronic acid (2.6 g, 21 mmol), and Pd (PPh 3 ) 4 (0.24 g, 0.21 mmol), which were finally synthesized in Preparation Example 2, were placed in a flask, and then toluene 140 was added under a nitrogen atmosphere. 70 ml of an aqueous solution of sodium carbonate (4.4 g, 31.5 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 고체의 화합물 19(7.7 g, 수율 81 %)를 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to give compound 19 (7.7 g, 81% yield) as a solid.

GC-Mass (이론치: 452.07 g/mol, 측정치: 452 g/mol)GC-Mass (Theoretical value: 452.07 g / mol, Measured value: 452 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv G-2의 합성 Synthesis of G-2

상기 준비예 3에서 최종 합성한 화합물 (10.2 g, 24.3mmol), 상기 <단계 1>에서 합성한 화합물 19(10.9 g, 24.3mmol) 및 Pd(PPh3)4 (0.28 g, 0.24 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 160 ㎖에 용해시킨 후 Sodium Carbonate (5.09 g, 48.0 mmol)을 녹인 수용액 80 ㎖를 첨가하여 이틀동안 환류 교반하였다. The compound (10.2 g, 24.3 mmol) finally synthesized in Preparation Example 3, the compound 19 (10.9 g, 24.3 mmol) and Pd (PPh 3 ) 4 (0.28 g, 0.24 mmol) synthesized in <Step 1> were flasked. It was dissolved in 160 ml of Toluene under a nitrogen atmosphere, and 80 ml of an aqueous solution of sodium carbonate (5.09 g, 48.0 mmol) was added thereto, followed by stirring under reflux for two days.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv G-2(7.5 g, 수율 60 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to afford the title compound Inv G-2 (7.5 g, yield 60%) as a white solid.

GC-Mass (이론치: 594.15 g/mol, 측정치: 594 g/mol)GC-Mass (Theoretical value: 594.15 g / mol, Measured value: 594 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.80 ~ 6.86 (m, 3H), 6.96 ~ 7.02 (m, 4H), 7.38 ~ 7.48 (m, 6H) 7.70 ~ 7.75 (m, 3H), 7.82 ~ 7.88 (m, 2H), 8.10 ~ 8.12 (m, 3H), 8.34(m, 2H), 8.93~8.99 (m, 3H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.80 to 6.86 (m, 3H), 6.96 to 7.02 (m, 4H), 7.38 to 7.48 (m, 6H) 7.70 to 7.75 (m, 3H) , 7.82 to 7.88 (m, 2H), 8.10 to 8.12 (m, 3H), 8.34 (m, 2H), 8.93 to 8.99 (m, 3H).

<< 합성예Synthetic example 14> 화합물  14> Compound InvInv G- G- 10 의10 of 합성 synthesis

Figure 112009081810135-PAT00045
Figure 112009081810135-PAT00045

<단계 1> 화합물 19의 합성Step 1 Synthesis of Compound 19

상기 <준비예 2>에서 최종 합성한 화합물 18(21.3 g, 40.6mmol), phenylboronic acid (5 g, 40.6 mmol) 및 Pd(PPh3)4 (0.47 g, 0.406 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 203 ㎖에 용해시킨 후 Sodium carbonate (6.9 g, 64.9 mmol)을 녹인 수용액 102 ㎖를 첨가하여 12시간 동안 환류 교반하였다. Compound 18 (21.3 g, 40.6 mmol), phenylboronic acid (5 g, 40.6 mmol), and Pd (PPh 3 ) 4 (0.47 g, 0.406 mmol), which were finally synthesized in Preparation Example 2, were placed in a flask under a nitrogen atmosphere. After dissolving in 203 mL of toluene, 102 mL of an aqueous solution of sodium carbonate (6.9 g, 64.9 mmol) was added thereto, and the mixture was stirred under reflux for 12 hours.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 7 : 3 (v:v))로 정제하여 고체의 화합물 19 (14.9 g, 수율 82 %)를 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 7: 3 (v: v)) to give compound 19 (14.9 g, yield 82%) as a solid.

GC-Mass (이론치: 452.07 g/mol, 측정치: 452 g/mol)GC-Mass (Theoretical value: 452.07 g / mol, Measured value: 452 g / mol)

<단계 2> 화합물 <Step 2> Compound InvInv G-10의 합성 Synthesis of G-10

상기 준비예 4에서 최종 합성한 화합물(9.6 g, 24.0mmol), 상기 <단계 1>에서 합성한 화합물 19(10.8 g, 24.0mmol) 및 Pd(PPh3)4 (0.28 g, 0.24 mmol)을 플라스크에 넣고 질소 분위기 하에 Toluene 160 ㎖에 용해시킨 후 Sodium Carbonate (5.09 g, 48.0 mmol)을 녹인 수용액 80 ㎖를 첨가하여 이틀동안 환류 교반하였다. The compound (9.6 g, 24.0 mmol) finally synthesized in Preparation Example 4, the compound 19 (10.8 g, 24.0 mmol) and Pd (PPh 3 ) 4 (0.28 g, 0.24 mmol) synthesized in <Step 1> were flasked. It was dissolved in 160 ml of Toluene under a nitrogen atmosphere, and 80 ml of an aqueous solution of sodium carbonate (5.09 g, 48.0 mmol) was added thereto, followed by stirring under reflux for two days.

반응이 종결된 후 디클로로메탄 50 ml로 3회 추출 후 추출액을 과량의 Magnesium sulphate로 건조, 여과하고 여액을 감압 농축하였다. 조 산물을 실리카겔 컬럼 크로마토그래피(n-Hexane: Dichloromethane = 4 : 1 (v:v))로 정제하여 백색 고체의 원하는 표제 화합물 Inv G-10(8.7 g, 수율 72 %)을 수득하였다.After the reaction was terminated and extracted three times with 50 ml of dichloromethane, the extract was dried with excess Magnesium sulphate, filtered and the filtrate was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography (n-Hexane: Dichloromethane = 4: 1 (v: v)) to afford the title compound Inv G-10 (8.7 g, 72% yield) as a white solid.

GC-Mass (이론치: 578.17 g/mol, 측정치: 578 g/mol)GC-Mass (Theoretical value: 578.17 g / mol, Measured value: 578 g / mol)

1H-NMR (THF-d8, 500MHz) d (ppm) 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.12 ~ 7.18 (m, 4H), 7.38 ~ 7,48 (m, 5H), 7.70 ~ 7.88 (m, 5H), 8.10 ~ 8.12 (m, 3H), 8.34(m, 2H), 8.93 ~ 8.99 (m, 3H). 1 H-NMR (THF-d 8 , 500 MHz) d (ppm) 6.72 (m, 1H), 6.84 (m, 1H), 6.96 (m, 1H), 7.12 to 7.18 (m, 4H), 7.38 to 7, 48 (m, 5H), 7.70-7.88 (m, 5H), 8.10-8.12 (m, 3H), 8.34 (m, 2H), 8.93-8.99 (m, 3H).

<< 실시예Example 1 내지 14> 유기  1 to 14> organic ELEL 소자의 제조 Manufacture of device

ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정한 후 진공 층착기로 기판을 이송하였다. A glass substrate coated with ITO (Indium tin oxide) having a thickness of 1500 Å was washed with distilled water ultrasonically. After washing with distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. is dried and transferred to a UV OZONE cleaner (Power sonic 405, Hwasin Tech). The substrate was transferred to the depositor.

이렇게 준비된 ITO 투명 전극 위에 m-MTDATA(60nm)/TCTA(80nm)/합성예 1-14에서 합성한 각각의 화합물 + 10% Ir(ppy)3(300nm)/BCP(10nm)/Alq3(30 nm)/LiF(1nm)/Al(200nm) 순으로 유기 EL 소자를 제조하였다.M-MTDATA (60 nm) / TCTA (80 nm) / each compound synthesized in Synthesis Example 1-14 on the prepared ITO transparent electrode + 10% Ir (ppy) 3 (300 nm) / BCP (10 nm) / Alq 3 (30 nm) ) / LiF (1 nm) / Al (200 nm) in order to manufacture an organic EL device.

m-MTDATA, TCTA, CBP, Ir(ppy)3, 및 BCP의 구조는 아래와 같다.The structures of m-MTDATA, TCTA, CBP, Ir (ppy) 3 , and BCP are as follows.

Figure 112009081810135-PAT00046
Figure 112009081810135-PAT00046

m-m- MTDATAMTDATA TCTATCTA

Figure 112009081810135-PAT00047
Figure 112009081810135-PAT00048
Figure 112009081810135-PAT00047
Figure 112009081810135-PAT00048

CBPCBP IrIr (( ppyppy )33

Figure 112009081810135-PAT00049
Figure 112009081810135-PAT00049

BCPBCP

<< 비교예Comparative example 1> 유기  1> organic ELEL 소자의 제조 Manufacture of device

발광층 형성시 합성예에서 제조된 화합물 대신 CBP를 발광호스트 물질로 사용한 것을 제외하고는, 실시예 1과 동일한 방법으로 유기 EL 소자를 제조하였다.An organic EL device was manufactured in the same manner as in Example 1, except that CBP was used as a light emitting host material, instead of the compound prepared in Synthesis Example, to form an emission layer.

<< 평가예Evaluation example >>

실시예 1-14 및 비교예 1에서 제조된 각각의 유기 EL 소자에 대하여 구동전압, 전류효율, 발광 피크 및 녹색광에서의 휘도를 측정하고, 그 결과를 하기 표 1에 나타내었다. For each organic EL device manufactured in Example 1-14 and Comparative Example 1, the driving voltage, current efficiency, emission peak, and luminance at green light were measured, and the results are shown in Table 1 below.

소자device HostHost 전압(V)Voltage (V) 휘도(cd/m2)Brightness (cd / m 2 ) EL peak(nm)EL peak (nm) 전류효율(cd/A)Current efficiency (cd / A) 실시예 1Example 1 A-2A-2 7.287.28 452452 520520 43.443.4 실시예 2Example 2 A-4A-4 7.127.12 418418 519519 40.740.7 실시예 3Example 3 A-12A-12 7.027.02 435435 519519 41.441.4 실시예 4Example 4 A-28A-28 6.856.85 442442 521521 42.542.5 실시예 5Example 5 A-29A-29 6.956.95 386386 518518 37.237.2 실시예 6Example 6 A-30A-30 6.826.82 430430 518518 41.541.5 실시예 7Example 7 B-2B-2 6.346.34 412412 517517 40.540.5 실시예 8Example 8 B-4B-4 6.256.25 404404 516516 38.138.1 실시예 9Example 9 B-12B-12 6.696.69 427427 518518 40.840.8 실시예 10Example 10 B-28B-28 6.526.52 455455 518518 43.743.7 실시예 11Example 11 B-29B-29 6.626.62 401401 518518 37.437.4 실시예 12Example 12 B-30B-30 6.306.30 435435 517517 41.641.6 실시예 13Example 13 G-2G-2 6.956.95 425425 517517 38.538.5 실시예 14Example 14 G-10G-10 6.876.87 410410 517517 37.237.2 비교예 1Comparative Example 1 CBPCBP 6.936.93 445445 516516 38.238.2

상기 표 1의 결과로부터 알 수 있는 바와 같이, 본 발명에 따른 화합물을 녹색 유기 EL 소자의 발광층으로 사용하였을 경우(실시예)는 종래 CBP를 사용한 녹색 유기 EL 소자(비교예 1)와 대비하여 볼 때 효율 및 전압 면에서 월등한 성능을 나타내는 것을 확인할 수 있다.As can be seen from the results of Table 1 above, when the compound according to the present invention was used as the light emitting layer of the green organic EL device (Example), it was compared with the green organic EL device using the CBP (Comparative Example 1). It can be seen that it shows excellent performance in terms of efficiency and voltage.

이상을 통해 본 발명의 바람직한 실시예에 대하여 설명하였지만, 본 발명은 이에 한정되는 것이 아니고 특허청구범위와 발명의 상세한 설명의 범위 안에서 여러 가지로 변형하여 실시하는 것이 가능하고 이 또한 본 발명의 범위에 속하는 것은 당연하다.Although the preferred embodiments of the present invention have been described above, the present invention is not limited thereto, and various modifications and changes can be made within the scope of the claims and the detailed description of the invention. It is natural to belong.

Claims (8)

하기 화학식 1로 표시되는 화합물: Compound represented by the following formula (1): <화학식 1><Formula 1>
Figure 112009081810135-PAT00050
Figure 112009081810135-PAT00050
상기 식에서, Where X는 황 또는 산소 원자이고; X is sulfur or oxygen atom; R1 내지 R20은 각각 독립적으로 수소, 중수소, 할로겐, 치환 또는 비치환된 C1-C40 알킬, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, 치환 또는 비치환된 C1-C40 알콕시, 치환 또는 비치환의 C3-C40 사이클로알킬, 치환 또는 비치환의 핵원자수 3 내지 40의 헤테로사이클로알킬, 치환 또는 비치환된 C5-C40 아릴, 치환 또는 비치환된 C5-C60 아릴옥시, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬, 치환 또는 비치환된 C2-C40 알케닐, 치환 또는 비치환된 C1-C40 알킬아민, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬아민, 치환 또는 비치환된 C1-C40 알킬실릴, 치환 또는 비치환된 C5-C40 아릴실릴, 치환 또는 비치환된 C7-C40 케토아릴, 치환 또는 비치환된 C1- C40 할로알킬 또는 시아노이며, R1 내지 R20은 서로 인접하는 기와 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있으며;R 1 to R 20 are each independently hydrogen, deuterium, halogen, substituted or unsubstituted C1-C40 alkyl, substituted or unsubstituted nuclear atom having 3 to 60 heterocycles, substituted or unsubstituted nuclear atom having 5 to 40 heteroaryl, substituted or unsubstituted C1-C40 alkoxy, substituted or unsubstituted C3-C40 cycloalkyl, substituted or unsubstituted heterocycloalkyl having 3 to 40 nuclear atoms, substituted or unsubstituted C5-C40 aryl, Substituted or unsubstituted C5-C60 aryloxy, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl, substituted or unsubstituted C2-C40 alkenyl, substituted or unsubstituted C1-C40 alkylamine, ( Substituted or unsubstituted C5-C60 aryl) C1-C40 alkylamine, substituted or unsubstituted C1-C40 alkylsilyl, substituted or unsubstituted C5-C40 arylsilyl, substituted or unsubstituted C7-C40 ketoaryl, substituted or unsubstituted C1- C40 alkyl, and halo or cyano ring, R 1 to R 20 are adjacent to each other Combined with the condensate to form a (fused) aliphatic ring, a condensed aromatic ring, a condensed heterocyclic aliphatic ring or fused heteroaromatic ring of 5 to 40 nuclear atoms, and; L은 치환 또는 비치환된 C5-C60 아릴, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬, 치환 또는 비치환된 C5-C40 아릴아민, 치환 또는 비치환된 C5-C60 아릴옥시, 치환 또는 비치환된 C5-C40 아릴실릴, 또는 치환 또는 비치환된 C7-C40 케토아릴이며, L이 치환기를 가질 경우 인접하는 치환기는 서로 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있다.L is substituted or unsubstituted C5-C60 aryl, substituted or unsubstituted heteroatom having 3 to 60 heteroatoms, substituted or unsubstituted heteroatom having 5 to 40 heteroaryl, (substituted or unsubstituted C5- C60 aryl) C1-C40 alkyl, substituted or unsubstituted C5-C40 arylamine, substituted or unsubstituted C5-C60 aryloxy, substituted or unsubstituted C5-C40 arylsilyl, or substituted or unsubstituted C7-C40 Ketoaryl, when L has a substituent, adjacent substituents may be bonded to each other to form a fused aliphatic ring, a fused aromatic ring, a fused heteroaliphatic ring, or a fused heteroaromatic ring having 5 to 40 nuclear atoms.
제 1 항에 있어서,The method of claim 1, 상기 L, R1 내지 R20의 알킬, 헤테로환, 헤테로아릴, 알콕시, 사이클로알킬, 헤테로사이클로알킬, 아릴, 아릴옥시, 아릴알킬, 알케닐, 알킬아민, 아릴 알킬아민, 알킬실릴, 아릴실릴, 케토아릴, 및 할로알킬의 치환기는 각각 독립적으로 중수소, 할로겐, C1-C40 알킬, 핵원자수 3 내지 60의 헤테로환, 핵원자수 5 내지 40의 헤테로아릴, C1-C40 알콕시, C3-C40 사이클로알킬, 핵원자수 3 내지 40의 헤테로사이클로알킬, C5-C40 아릴, C5-C60 아릴옥시, (C5-C60 아릴)C1-C40 알킬, C2-C40 알케닐, C1-C40 알킬아민, (C5-C60 아릴)C1-C40 알킬아민, C1-C40 알킬실릴, C5-C40 아릴실릴, C7-C40 케토아릴, C1-C40 할로알킬 및 시아노로 구성된 군에서 선택되는 하나 이상인 것을 특징으로 하는 화합물.Wherein L, R 1 to the R 20 alkyl, heterocycle, heteroaryl, alkoxy, cycloalkyl, heterocycloalkyl, aryl, aryloxy, arylalkyl, alkenyl, alkyl amines, arylalkyl amines, alkyl silyl, aryl silyl, The substituents of ketoaryl and haloalkyl are each independently deuterium, halogen, C1-C40 alkyl, heterocycle having 3 to 60 nuclear atoms, heteroaryl having 5 to 40 nuclear atoms, C1-C40 alkoxy, C3-C40 cyclo Alkyl, heterocycloalkyl of 3 to 40 nuclear atoms, C5-C40 aryl, C5-C60 aryloxy, (C5-C60 aryl) C1-C40 alkyl, C2-C40 alkenyl, C1-C40 alkylamine, (C5- C60 aryl) C1-C40 alkylamine, C1-C40 alkylsilyl, C5-C40 arylsilyl, C7-C40 ketoaryl, C1-C40 haloalkyl and cyano. 제 1 항에 있어서,The method of claim 1, 상기 화학식 1의 화합물은 하기 화학식 1a 또는 1b의 화합물인 것을 특징으로 하는 화합물:The compound of formula 1 is a compound characterized in that the compound of formula 1a or 1b: <화학식 1a><Formula 1a>
Figure 112009081810135-PAT00051
Figure 112009081810135-PAT00051
<화학식 1b><Formula 1b>
Figure 112009081810135-PAT00052
Figure 112009081810135-PAT00052
상기 식에서,Where X, L, R1 내지 R20은 제 1 항에서 정의된 바와 같다.X, L, R 1 to R 20 are as defined in claim 1.
제 1 항에 있어서,The method of claim 1, 상기 L은 하기 화학식 2로 구성된 군으로부터 선택되는 것을 특징으로 하는 화합물:Wherein L is a compound characterized in that it is selected from the group consisting of: <화학식 2><Formula 2>
Figure 112009081810135-PAT00053
Figure 112009081810135-PAT00053
상기 식에서, Where R21 내지 R24는 각각 독립적으로 수소, 중수소, 할로겐, 치환 또는 비치환된 C1-C40 알킬, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, 치환 또는 비치환된 C1-C40 알콕시, 치환 또는 비치환의 C3-C40 사이클로알킬, 치환 또는 비치환의 핵원자수 3 내지 40의 헤테로사이클로알킬, 치환 또는 비치환된 C5-C40 아릴, 치환 또는 비치환된 C5-C60 아릴옥시, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬, 치환 또는 비치환된 C2-C40 알케닐, 치환 또는 비치환된 C1-C40 알킬아민, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬아민, 치환 또는 비치환된 C1-C40 알킬실릴, 치환 또는 비치환된 C5-C40 아릴실릴, 치환 또는 비치환된 C7-C40 케토아릴, 치환 또는 비치환된 C1-C40 할로알킬 또는 시아노이며, R21 내지 R24는 서로 인접하는 기와 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있다.R 21 to R 24 are each independently hydrogen, deuterium, halogen, substituted or unsubstituted C1-C40 alkyl, substituted or unsubstituted heteroatom having 3 to 60 heterocycles, substituted or unsubstituted nucleus 5 to 5 40 heteroaryl, substituted or unsubstituted C1-C40 alkoxy, substituted or unsubstituted C3-C40 cycloalkyl, substituted or unsubstituted heterocycloalkyl having 3 to 40 nuclear atoms, substituted or unsubstituted C5-C40 aryl, Substituted or unsubstituted C5-C60 aryloxy, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl, substituted or unsubstituted C2-C40 alkenyl, substituted or unsubstituted C1-C40 alkylamine, ( Substituted or unsubstituted C5-C60 aryl) C1-C40 alkylamine, substituted or unsubstituted C1-C40 alkylsilyl, substituted or unsubstituted C5-C40 arylsilyl, substituted or unsubstituted C7-C40 ketoaryl, substituted or unsubstituted C1-C40 alkyl, and halo or cyano ring, R 21 to R 24 are adjacent to each other And it may be bonded to form a condensed (fused) aliphatic ring, a condensed aromatic ring, a condensed heterocyclic aliphatic ring or fused heteroaromatic ring of 5 to 40 nuclear atoms.
제 1 항에 있어서,The method of claim 1, 상기 L은 하기 화학식 3으로 구성된 군으로부터 선택되는 것을 특징으로 하는 화합물:Wherein L is selected from the group consisting of <화학식 3> <Formula 3>
Figure 112009081810135-PAT00054
Figure 112009081810135-PAT00054
상기 식에서,Where R21 및 R22는 각각 독립적으로 수소, 중수소, 할로겐, 치환 또는 비치환된 C1-C40 알킬, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, 치환 또는 비치환된 C1-C40 알콕시, 치환 또는 비치환의 C3-C40 사이클로알킬, 치환 또는 비치환의 핵원자수 3 내지 40의 헤테로사이클로알킬, 치환 또는 비치환된 C5-C40 아릴, 치환 또는 비치환된 C5-C60 아릴옥시, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬, 치환 또는 비치환된 C2-C40 알케닐, 치환 또는 비치환된 C1-C40 알킬아민, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬아민, 치환 또는 비치환된 C1-C40 알킬실릴, 치환 또는 비치환된 C5-C40 아릴실릴, 치환 또는 비치환된 C7-C40 케토아릴, 치환 또는 비치환된 C1-C40 할로알킬 또는 시아노이고;R 21 and R 22 are each independently hydrogen, deuterium, halogen, substituted or unsubstituted C1-C40 alkyl, substituted or unsubstituted heteroatom having 3 to 60 heterocycles, substituted or unsubstituted nucleus 5 to 5 40 heteroaryl, substituted or unsubstituted C1-C40 alkoxy, substituted or unsubstituted C3-C40 cycloalkyl, substituted or unsubstituted heterocycloalkyl having 3 to 40 nuclear atoms, substituted or unsubstituted C5-C40 aryl, Substituted or unsubstituted C5-C60 aryloxy, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl, substituted or unsubstituted C2-C40 alkenyl, substituted or unsubstituted C1-C40 alkylamine, ( Substituted or unsubstituted C5-C60 aryl) C1-C40 alkylamine, substituted or unsubstituted C1-C40 alkylsilyl, substituted or unsubstituted C5-C40 arylsilyl, substituted or unsubstituted C7-C40 ketoaryl, substituted Or unsubstituted C1-C40 haloalkyl or cyano; 복수 개의 Z 중 적어도 하나는 질소 원자이고 나머지는 탄소 원자이며, Z에 부착된 수소 원자는 비치환되거나 중수소, 할로겐, 치환 또는 비치환된 C1-C40 알 킬, 치환 또는 비치환된 핵원자수 3 내지 60의 헤테로환, 치환 또는 비치환된 핵원자수 5 내지 40의 헤테로아릴, 치환 또는 비치환된 C1-C40 알콕시, 치환 또는 비치환된 C3-C40 사이클로알킬, 치환 또는 비치환된 핵원자수 3 내지 40의 헤테로사이클로알킬, 치환 또는 비치환된 C5-C40 아릴, 치환 또는 비치환된 C5-C60 아릴옥시, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬, 치환 또는 비치환된 C2-C40 알케닐, 치환 또는 비치환된 C1-C40 알킬아민, (치환 또는 비치환된 C5-C60 아릴)C1-C40 알킬아민, 치환 또는 비치환된 C1-C40 알킬실릴, 치환 또는 비치환된 C5-C40 아릴실릴, 치환 또는 비치환된 C7-C40 케토아릴, 치환 또는 비치환된 C1-C40 할로알킬 또는 시아노로 치환될 수 있으며, 이들 치환기, R21 및 R22는 서로 인접하는 기와 결합하여 핵원자수 5 내지 40의 축합(fused) 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리 또는 축합 헤테로방향족 고리를 형성할 수 있다.At least one of the plurality of Z is a nitrogen atom and the rest are carbon atoms, and the hydrogen atom attached to Z is unsubstituted or deuterium, halogen, substituted or unsubstituted C1-C40 alkyl, substituted or unsubstituted nuclear atom 3 Heterocyclic, substituted or unsubstituted nuclear atoms of 5 to 40 heteroaryl, substituted or unsubstituted C1-C40 alkoxy, substituted or unsubstituted C3-C40 cycloalkyl, substituted or unsubstituted nuclear atoms 3 to 40 heterocycloalkyl, substituted or unsubstituted C5-C40 aryl, substituted or unsubstituted C5-C60 aryloxy, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkyl, substituted or unsubstituted C2-C40 alkenyl, substituted or unsubstituted C1-C40 alkylamine, (substituted or unsubstituted C5-C60 aryl) C1-C40 alkylamine, substituted or unsubstituted C1-C40 alkylsilyl, substituted or unsubstituted C5-C40 arylsilyl, substituted or unsubstituted C7-C40 ketoaryl, substituted or non Hwandoen C1-C40 haloalkyl, or cyano, and the furnace may be substituted, these substituents, R 21 and R 22 are nuclear atoms combine groups which are adjacent to each other 5-40 condensed (fused) aliphatic ring, a condensed aromatic ring, a condensed heterocyclic aliphatic It may form a ring or a condensed heteroaromatic ring.
양극; 음극; 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기층을 포함하는 유기 전계발광 소자로서,anode; cathode; And at least one organic layer interposed between the anode and the cathode, wherein the organic electroluminescent device comprises: 상기 유기층 중 적어도 하나는 제 1 항 내지 제 5 항 중 어느 한 항에 따른 화합물을 포함하는 것을 특징으로 하는 유기 전계발광 소자.At least one of the organic layers comprises an organic electroluminescent device, characterized in that the compound according to any one of claims 1 to 5. 제 6 항에 있어서, The method of claim 6, 상기 유기층은 발광층, 전자수송층, 정공 주입층 및 정공 수송층으로 구성된 군으로부터 선택되는 것을 특징으로 하는 유기 전계발광 소자.The organic layer is an organic electroluminescent device, characterized in that selected from the group consisting of a light emitting layer, an electron transport layer, a hole injection layer and a hole transport layer. 제 6 항에 있어서, The method of claim 6, 상기 화합물은 인광 호스트 물질 또는 형광 호스트 물질인 것을 특징으로 하는 유기 전계발광 소자.The compound is an organic electroluminescent device, characterized in that the phosphorescent host material or a fluorescent host material.
KR1020090134520A 2009-12-30 2009-12-30 Triphenylene-based compounds and organic electroluminescent device comprising same KR101196142B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020090134520A KR101196142B1 (en) 2009-12-30 2009-12-30 Triphenylene-based compounds and organic electroluminescent device comprising same
PCT/KR2010/009508 WO2011081451A2 (en) 2009-12-30 2010-12-29 Tri-phenyl compounds and organic electro-luminescent device using same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090134520A KR101196142B1 (en) 2009-12-30 2009-12-30 Triphenylene-based compounds and organic electroluminescent device comprising same

Publications (2)

Publication Number Publication Date
KR20110077851A true KR20110077851A (en) 2011-07-07
KR101196142B1 KR101196142B1 (en) 2012-10-30

Family

ID=44227048

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090134520A KR101196142B1 (en) 2009-12-30 2009-12-30 Triphenylene-based compounds and organic electroluminescent device comprising same

Country Status (2)

Country Link
KR (1) KR101196142B1 (en)
WO (1) WO2011081451A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9972789B2 (en) 2014-01-16 2018-05-15 Samsung Display Co., Ltd. Organic light-emitting device
WO2024101948A1 (en) * 2022-11-11 2024-05-16 주식회사 엘지화학 Compound and organic light-emitting element comprising same

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5606861B2 (en) * 2010-09-30 2014-10-15 ユー・ディー・シー アイルランド リミテッド Material for organic electroluminescent element, film, light emitting layer, organic electroluminescent element, and method for producing organic electroluminescent element
GB2537195B (en) * 2013-04-09 2017-12-13 Power Oleds Ltd Heterocyclic compounds and their use in electro-optical or opto-electronic devices
GB201306365D0 (en) 2013-04-09 2013-05-22 Kathirgamanathan Poopathy Heterocyclic compounds and their use in electro-optical or opto-electronic devices
KR101779110B1 (en) * 2013-10-11 2017-09-18 제일모직 주식회사 Organic optoelectric device and display device
US20170092875A1 (en) 2014-03-18 2017-03-30 Merck Patent Gmbh Organic electroluminescent device
KR101818581B1 (en) * 2014-10-31 2018-01-15 삼성에스디아이 주식회사 Organic optoelectric device and display device
CN104844587B (en) * 2015-04-29 2018-06-01 深圳市华星光电技术有限公司 Conjugated compound containing phenoxazine thiophene structure and preparation method thereof and organic electroluminescent diode apparatus
KR20170069342A (en) * 2015-12-10 2017-06-21 삼성디스플레이 주식회사 Organic light-emitting device
KR101916572B1 (en) * 2016-04-12 2018-11-07 주식회사 엘지화학 Compound and organic light electronic device comprising the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100994083B1 (en) * 2003-07-31 2010-11-12 미쓰비시 가가꾸 가부시키가이샤 Compound, charge transport material and organic electroluminescent device
JP5109236B2 (en) * 2004-06-09 2012-12-26 三菱化学株式会社 Hole blocking material and organic electroluminescent device
JP2006143845A (en) * 2004-11-18 2006-06-08 Konica Minolta Holdings Inc Material for organic electroluminescent element, organic electroluminescent element, lighting equipment and display device
JP2009114068A (en) * 2007-11-01 2009-05-28 Canon Inc Triphenylene compound and organic light-emitting device by using the same
KR100910150B1 (en) 2008-04-02 2009-08-03 (주)그라쎌 Novel organic electroluminescent compounds and organic electroluminescent device using the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9972789B2 (en) 2014-01-16 2018-05-15 Samsung Display Co., Ltd. Organic light-emitting device
WO2024101948A1 (en) * 2022-11-11 2024-05-16 주식회사 엘지화학 Compound and organic light-emitting element comprising same

Also Published As

Publication number Publication date
WO2011081451A2 (en) 2011-07-07
KR101196142B1 (en) 2012-10-30
WO2011081451A3 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
KR101196142B1 (en) Triphenylene-based compounds and organic electroluminescent device comprising same
KR101183722B1 (en) Triphenylene-based compounds and organic electroluminescent device comprising same
KR101218029B1 (en) Triphenylene-based compounds that substitute aryl amine compounds and organic electroluminescent device comprising same
KR101452578B1 (en) Novel compounds and organic electro luminescence device using the same
KR20180069475A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR101618426B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101612174B1 (en) Organic compound and organic electroluminescent device comprising the same
KR101829108B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150047858A (en) Organic compounds and organic electro luminescence device comprising the same
KR102263822B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102499850B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR20140079595A (en) Organic compounds and organic electro luminescence device comprising the same
KR20140145451A (en) Organic compounds and organic electro luminescence device comprising the same
KR20230040969A (en) Organic compound and organic electroluminescent device using the same
KR20170058177A (en) Organic compounds and organic electro luminescence device comprising the same
KR20170132493A (en) Organic light-emitting compound and organic electroluminescent device using the same
KR101603384B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101577112B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101985740B1 (en) Hetero-cyclic compound and organic light emitting device comprising the same
KR20150086084A (en) Organic compounds and organic electro luminescence device comprising the same
KR101612158B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101548040B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20200077880A (en) Organic compound and organic electroluminescent device using the same
KR20180113921A (en) Organic light emitting device
KR102587493B1 (en) Organic light-emitting compound and organic electroluminescent device using the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20151007

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20161004

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee